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1.1. High-performance sensing 
     Reporting clinically relevant biomolecular interactions is mandatory in the field of medical 
diagnosis.  Recognition of biomolecular interaction is considered as an important event to convey the 
importance for a wide range of disciplines to understand the events of disease and gene regulations. A 
biosensor is an analytical device, made by a combination of a biological component with a 
physicochemical detector that assists in the detection of biomolecular interactions. A biosensor detects 
extremely small amounts of biochemical agents, such as proteins, nucleic acid, bio-mimetic polymers, 
in a given sample. First reported biosensor was in 1962 having signal recognition elements and 
transducers, as the basic for sensor development.1 Nanomaterials can facilitate signal transduction 
with electroactive tags for sensing and imaging purposes.  Benefits obtained from nanotechnology 
mainly depend on specific tailored materials designed with essential structures at the nanoscale level 
to achieve a specific goal, thus greatly extending the range of applications, including diagnosis.   
 
1.1.1. Gold sensing surface 
Among  several nanomaterials that have been fabricated, gold (Au) is an ideal material that is 
widely used in the development of sensors, owing to its unique characteristics, such as easy water 
dispersal, compatibility with surface functionalization, biological non-reactivity, anti-oxidation, high-
conductivity and ability to be tailored with uniform and different nano-sizes.2,3,4  Original Au material 
does not have any charges, however, getting surface charges when undergo the preparation of 
nanostructures.  Gold nanostructures consist negative surface charges in most of the cases and 
positive charged nanostructures can also be prepared. Au sensing surface can be chemically 
functionalized by Au-S linkage and exchange reaction with thiolated compounds, examples 
mercaptohexadecanoic acid and mercaptopropionic acid.  Au adsorb in the visible light spectrum 
around 520 nm (green light) due to the excitation of plasmons in the particle and this wavelength can 
be adapted to several optical sensors.5,6 In the past, several attractive Au-based sensing surfaces 
have emerged, and the applications of these surfaces have expanded to sensor development
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in conjunction with various fields.7-14  Usually thin layer of Au tends to be less stable and it can be 
overcome by making a hybridized surface of Au with other materials such as, chromium and silica. 
 
1.1.2. Silica sensing surface  
 Other than Au, sensors on silicon (Si) and silica or dioxide of silicon (SiO2) substrates are widely 
used in the analysis of biomoecular interactions.15-17 Si is an abundant, low-cost material as compared 
to noble metals. Amourpous and variety of crystal forms of SiO2 materials are quite common; in 
addition due to smoothness of crystal form of SiO2, it is more suitable for sensing applications. SiO2 
will occur as a non-crystalline oxidation product on the surface of Si or Si compounds.  These 
materials can be prepared by Czochralski technique has been conventionally used crystal growth 
method for the growth of single crystal ingots. Quartz, tridymite and cristobalite are three forms of 
crystalline  forms of SiO2.  A high quality SiO2 layer grown on the Si and SiO2 always carry the positive 
charges. These substrates can be made with wide variations in the degree of packing leads to 
differences in the densities, thicknesses, and morphologies of the deposited films.18 Furthermore, Si 
and SiO2 are inert against most chemicals and physical conditions. SiO2 materials are very commonly 
chemically functionalized by silane (amine) coupling reagents. The above described two materials (Au 
and SiO2) are highly preferable in sensing surface developments, their high performances are 
displayed when hybridized with other materials such as polymers. 
 
1.1.3. Polymer-hybridized sensing surface 
The major prerequisite of biosensors includes measuring the specific target in a sample 
containing mixture of compounds, without compromising the convenience and sensitivity.  Even 
though, the sensitivity varies with the different systems depends on various parameters, sensitivity is 
the determining factor for the quality of the sensor.19  One of the most important factors in improving 
the effectiveness of the sensor is the correct orientation of immobilized biomolecules on the sensing 
surface.20 It is also important to minimize non-specific biofouling as much as possible to improve the 
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signal to noise ratio (S/N). Natural polymers such as albumin, casein, and dextran are considered as 
candidates for suppressing the non-specific interaction on the sensor surface.21 However, the 
efficiency of these natural polymers is not completely satisfactory. High-performance surface 
modification techniques using synthetic polymers are highly anticipated to overcome these issues. 
Nagaoka and his co-workers in 1982 first reported that about a ‘poly(ethylene glycol) (PEG) polymer 
brush’, represents PEG chain-end immobilized on a sensing surface which forms a tethered chain. 
Several reports on PEG-chain-tethered surfaces have been published after their report.20 It was 
reported previously that a densely packed PEG tethered-chain surface shows high resistance to 
biofouling. In particular, a combination of long and short PEG chains greatly reduces non-specific 
adsorption of proteins onto the substrate surface. It is interesting to note that sensitivity is also 
increased when antibody was co-immobilized on mixed-PEG chain hybridized surface.22  For effective 
immobilization of PEG-derivatives on substrate surfaces, suitable anchoring strategies must be 
designed using specific interactions. It was also reported that multi-anchoring is one of the most 
effective ways of stably immobilizing PEG derivatives onto the substrate surface.23  Several types of 
PEG-based block copolymers, but not graft-type copolymers, have been used to construct highly 
stable, tether-like chains on the substrate surface. PEG block copolymers such as PEG-b-polycations, 
PEG-b-polyanions, and PEG-b-hydrophobic polymers have proven to be versatile materials. 
 
The objective of this work is stated below to establish high-performance PEG hybridized 
aptasensors on SiO2 and Au sensing surfaces.   The following targets, polymers and sensors were 
chosen to carry out this study. 
(i) To reduce the bio-fouling and to increase the non-fouling characters with higher specificity 
using poly(ethylene glycol)-block polymers (PEG-b-polymers), such as PEG-b-poly(acrylic 
acid) (PEG-b-PAAc), pentaethylenehexamine-terminated PEG (N6-PEG) and  PEG-b-poly[2-
(N,N-dimethylamino)ethyl methacrylate] (PEG-b-PAMA) as a blocking agents.  
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(ii)  Human coagulating factor IX protein (FIX) was chosen as a model analyte to interact anti-FIX 
aptamer, because FIX has extremely low availability in vivo and important to detect defects in 
human blood coagulation system.  Further, anti-influenza aptamers were generated to 
demonstrate and diagnosis of intact influenza viruses.  
(iii)  Sensor surfaces (SiO2 or Au) of Evanescent-field-coupled Waveguide-mode (EFC-WM), 
Surface Plasmon Resonance (SPR) and Surface Plasmon Fluorescence Spectroscopy 
(SPFS) were used to demonstrate the aptamer-protein interactions. 
The potential characteristics of the above molecules on PEG-b-polymer hybridized sensing 
surfaces are described below. 
 
1.2. PEG-b-polymers  
PEG is one of the popular polymers, which is chemically inert, provides terminal hydroxyl groups 
that can be used as anchors for functional groups, is nontoxic and disperable in water due to hydrogen 
bonding between water molecules and ether oxygen of PEG chain. PEG-b-polymers are attracted the 
researchers in the past especially in the fields of biotechnology, pharmaceutical and medicine for the 
purposes of bio-recognition, cosmetics, drug delivery systems and microsystems.24,25 PEG-based 
polymers are also driven an efficient role in the development of biointerfaces and for the applications 
of non-ionic surfactants, lubricants, and adhesives.20,26  PEG has been used as a blocking agent for 
the preventing nonspecific adsorption of binding materials when co-immobilized with ligands for 
targets such as antibodies and oligonucleotides.20 Surface modification with PEG (so-called 
PEGylation) is shown to have non-fouling due to biocompatibility of the polymers such as hydrophilic, 
and flexiblility.27-29 Grafting of nanostructures with PEG resulting the enhanced stability of suspensions 
due to steric repulsion.30 Moreover, PEGylated nanoparticles are connected with external stimuli-
responsive such as pH, temperature and ionic strength.31-34 These properties makes the PEG to be 
applicable to nano- or microscale particles.35 PEG-b-polymers found to reduce the nonspecificity to 
higher extend due to its characteristics such as low interfacial free energy in water and high chain 
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mobility, which stimulates excluded-volume effects.36  The length and density of the constructed 
polymers are grately play a role in the improvement of sensitivity and specificity of a 
given sensor.   However, increased chain-length tend be less densed due to steric exclusion of PEG-
chains on the immobilized surface .37,38   Instead, mixture of long and short PEG-chain overcome the 
density issues, by the occupying properties of short chain between the interface of two long chains.39  
Even though, different methods used to construct PEG tethered chains on sensing surfaces, two main 
techniques are common, known as the ‘grafting-from’ and ‘grafting-to’ methods; the former is used to 
construct PEG chains by the polymerization of vinyl monomers from a surface, and the latter involves 
the immobilization of polymer to a surface.20 Figure 1.1. summarizes different ways of immobilization 
of polymers on sensing substrate.   
 
 
Figure 1.1. PEG-tethered surface modifications.  Immobilization of different polymers is shown.  
Depends on the sensing surface to be preferred, the suitable polymer will be chosen (This figure is 
reproduced from Nagasaki, 2011).20 
 
These polymers are drastically reduce the back-ground noice and improve the sensitivity. 
Another advantages of polymers are having lower molecular weights (less than 10 kDa) than other 
blocking agents such as Bovine serum albumin (BSA) (66 kDa), casein (>20 kDa) and gelatin (>100 
kDa).  Higher molecular weight blocking cause interference with molecular recognition site of ligand 
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and analyte.20 To demonstrate the applications of PEG-b-polymers for the sensing applications, three 
types of polymers are desired to use in the present study for surface construction, 
namely, PEG-b-PAAc, N6-PEG and  PEG-b-PAMA (Figure 1.2). 
 
Figure 1.2. PEG-b-polymers.  Three kinds (PEG-b-PAAc, N6-PEG and PEG-b-PAMA) of polymers 
were used.  The chemical structures of polymers are shown.  Negative charged PEG-b-PAAc can bind 
on the positively charged amine surfaces. Polyvalent interactions between the end amino groups of 
N6-PEG interact on the Au surface. Polyamine segment of PEG-b-PAMA interacts with a Au surface 
via multipoint coordination by the tertiary amino groups. Regions of interaction are encircled (This 
figure is reproduced from Nagasaki, 2011).20 
 
1.2.1. PEG-b-poly(acrylic acid) (PEG-b-PAAc)  
Negative charged PEG-b-PAAc can bind on the positively charged surfaces, such as amine.  
Another example, PEG-b-PAAc effectively covers Y2O3 nanoparticles via an electrostatic interaction 
resulting from the positive charge of the yttrium oxide surface.40 It was reported that poly(acrylic 
acid)(PAAc) adsorbed nanoparticles can disperse in aqueous solutions due to electrostatic repulsion 
of the carboxyl groups of polymer.41 Hemmer et al. have reported that PEG-b-PAAc provides the 
chemical durability leads a good in vitro biocompatibility.42 They analysed bare and PEG-b-PAAc 
modified Erbium and ytterbium doped gadolinium oxide (Gd2O3:Er
3+,Yb3+) nanostructures and 
investigated of their in vitro cytotoxicity with B-cell hybridomas and macrophages and noticed no 
cytotoxic effect towards B-cell hybridomas, however, bare nanostructures shown a toxic effect on 
macrophages. The same team also tested the effect of PEG-b-PAAc modification on the in vitro 
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cellular up-take of Gd2O3:Er
3+,Yb3+ nanostructures by macrophages.43 PEG-b-PAAc
can be availed commercially. PEG-b-PAAc modifications on nanostructures provide a protecting layer 
and PEG-b-PAAc is suitable for providing chemical durability, dispersion stability, and noncytotoxic 
behaviour for biomedical applications30. In this work, the author used PEG-b-PAAC for the blocking 
agent on the amine modified surfaces.44 
 
1.2.2. Pentaethylenehexamine-terminated PEG (N6-PEG)  
PEG-b-polyamine is more suitble for the modification of Au surfaces for specific biorecognition. 
Polyvalent interactions between the end amino groups of N6-PEG interact on the Au surface. The 
coordination of the lone pair of the amino groups to the Au surface is involved in this reaction.22  This 
poly-amine interaction with Au-surface is long-term stable than a common Au-S linkage under varied 
physiological conditions.20,45 The coordination lone pair of the amino group is low with Au (3–6 kcalmol-
1) than Au-S linkage (~50 kcalmol-1) implies the strong interaction of N6-PEG.46  Concerning chain 
density on sensing surface by N6-PEG, was found to be 3 times higher than mono-amine-ended PEG.   
Moreover, electrostatic force of N6-PEG is totally differing from mono-ended chain. N6-PEG has both 
protonated and non-protonated amines in each PEG molecule and it show the pKa values of 2-10. 
Apart from Au surface, N6-PEG is also recommended for other surfaces, particularly active-ester 
surface. N6-PEG coated magnetic beads are having more stable dispersion than BSA coated beads.20  
N6-PEG can be availed commercially and greatly reduce the nonspecific binding of biomolecules, it’s 
considered as good blocking and specific recoganising agent for Au surface. The author used N6-PEG 
as the blocking agent on Au surface for this study. 
 
1.2.3. PEG-b-poly[2-(N,N-dimethylamino)ethyl methacrylate] (PEG-b-PAMA) 
 
The polyamine segment of PEG-b-PAMA interacts with a Au surface via multipoint coordination 
by the tertiary amino groups. Co-ordination of nitrogen atom with amine groups on PEG plays 
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an important part in immobilization process on Au surface, three nitrogen atoms 
on the PEG chain are sufficient for polyvalent coordination with Au.23 Miyamoto et al.47 have prepared 
a novel PEG-b-PAMA, having water-soluble, biocompatibility with controlled molecular weight. Co-
immobilization of PEG-b-PAMA and ssDNA promotes the sensitive detection, this might be due to, 
PEG-b-PAMA co-immobilized Au surface with SH-ssDNA inhibits the interaction of nucleobase of oligo 
and Au,21 leads to upright confirmation of immobilized ssDNA. This confirmation further supports by 
the proper duplex formation.48,49  Moreover, PEG-b-PAMA co-immobilized gold nanoparticle (GNP) 
with siRNA shown to have higher interference efficiency.50  It was found that adsorption of PEG-b-
PAMA on the Au surface was not affected by strong ionic condition and it indicates interaction of 
polyamine on the Au, rather than minor electrostatic attraction between polyamine and Au.51   The pKa 
value of the amino groups of PEG-b-PAMA is 7.0, indicates amino groups in the PAMA will depronate 
completely at pH 10.0.  This statement suggest that GNP can be stablilized by the neutral PEG-b-
PAMA, through co-ordination of amino nitrogen atoms.23  However, it was surprising that the purified 
PEG-GNP were stable at neutral pH, even though they are deprotonated, indicates after immobilize 
PEG on Au, they are stable and also cause changes in the pKa value of amino groups.23   
 
1.2.3.1. Synthesis of PEG-b-PAMA 
To synthesize PEG-b-PAMA, the procedure outlined by Miyamoto et al. can be followed.47 In 
brief, the purified Hydroxyl-terminated PEG (MeO-PEG-OH, MW: 5000) (50 g) by reprecipitation was 
dissolved in commercial tetrahydrofuran (THF, Kanto Chemical Co., Ltd.). The polymer was 
precipitated by pouring this solution into 2-propanol. Centrifugation at 2300 x g at 4 °C was followed to  
separate precipitated polymer and washed several times with 2-propanol and dried by evaporation. 
The residue was dissolved in 20 mL of benzene, lyophilized overnight and the purified MeO-PEG-OH 
(5 g) was dissolved in THF under a nitrogen atmosphere.  MeO-PEG-OH (300 mg) was dissolved in 
30 mL of THF under a nitrogen atmosphere.  MeO-PEG-O−K+ was prepared by adding potassium 
naphthalene, which was used as an initiator for the anionic addition polymerization. PEG-b-PAMA was 
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obtained via block copolymerization through the addition of 2-(N,N-dimethylamino)ethyl methacrylate 
(AMA). The precipitate was dissolved in distilled water and adjusted to pH 4.5 by adding 1 M HCl. After 
lyophilization, the protonated PEG-b-PAMA was purified by Soxhlet extraction with THF. The quality of 
the product was characterized, and its purity was determined by gel permeation chromatography and 
proton nuclear magnetic resonance spectroscopy.47,49 The author used PEG-b-PAMA on Au surface 
for this study. 
 
The comparison of basic characteristics of the above three PEG-b-polymers are shown in Table 
1.1.  It is expected that PEG-derived polymers hybridized biological probe and target interactions on 
sensing surface will yield potential output.  On the above PEG-b-polymer(s) hybridized sensing 
surface(s), the interactions of RNA-aptamers and target stated below (FIX or influenza virus), were 
analyzed. 
 
Table 1.1. Comparison among different PEG-b-polymers.  Different methods of preparations are 
involved.  The sizes and the chain lengths can be varied with the preparation. 
 
1.3. Generation of RNA-based probe for sensing applications 
Developing nucleic acid probes (RNA or DNA) have been followed for several decades, because 
most of the biological functions are performed by the involvement of nucleic acids. A functional probe 
such as nucleic acid must possess the genotype and phenotype that enables the survival of the 
molecule within its population. Early investigations by Sol Spiegelman and colleagues performed 
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Darwanian evolution in the test tube using RNA bacteriophage Qβ that produces copies of the viral 
Genome,52 by repeating several generations of the Qβ replicase-mediated RNA. This was the first 
experiment that attested the self-replicating property of the RNA that have the
phenotype and genotype to ‘reproduce’ and to evolve in vitro in the presence of selection pressure. 
This groundbreaking work pioneered the effort to look further into the other phenotypic capability of the 
RNA sequence, such as the ability of the RNA sequence in recognizing target with high binding affinity 
and specificity. Using this work as the basic foundation, several artificially evolved molecules have 
been generation by mutations (Figure 1.3a).  Further, library of mutants or completely randomized 
biomolecules was used to select the best molecules a so-called ‘aptamer’ (Figure 1.3b). 
 
Figure 1.3. Strategies of molecular generation.  (a) generation of artificial molecules from naturally 
evolved molecules by mutation. (b) Selection of high affinity molecules from library of mutants or 
completely random molecules.  
 
1.4. Aptamers 
Aptamers are artificially evolved molecules against specific targets, from small molecules to 
whole cells, which can be generated by the separation and amplification processes by making the 
complex of randomized RNA or DNA libraries with target.  This strategy involving an in vitro selection 
process, called ‘systematic evolution of ligands by exponential enrichment’ (SELEX).  This selection 
process mimics the natural selection of aptamers as reported in the case of riboswitches.53  A typical 
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aptamer generation process starts with library contains huge number of molecules and repeatation 
under stringent conditions.  Only high-affinity molecules are retained through successive selection 
cycles (Figure 1.4).  SELEX was developed by 3 independent researchers in 1990 as an approach to 
identifying selective molecules among a randomized combinatorial library of molecules, against 
different targets.54-56 Using the basic SELEX strategies, there are several other SELEX strategies have 
been generated (Figure 1.5). 
 
Figure 1.4.  Basic strategy and methods involved in the SELEX for RNA aptamer.  SELEX involves 
complex formation, separation and regeneration.  The size of the initial library can be altered. 
 
Selected aptamer undergo specific binding when the appropriate target such as, protein is available.  
These binding are accomplished due to either protein-induced aptamer folding or aptamer-induced 
protein folding or co-induced folding.57 (Figure 1.6). Aptamers are having the potential characteristics 
equal to the antibodies, in addition aptamers have appealing characters over antibodies (Table 1.2). 
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Figure 1.5. Different strategies of SELEX.  The number of selection cycles and molecular  generation 
are varied with each strategy. 
 
 
Figure 1.6. Strategies of aptamer-protein interactions.  Three possible structural changes occurred 
during interactions are shown. 
Chapter 1: General Introduction 
 
 
23 
 
 
Table 1.2.  Comparison of characteristics of aptamers and antibodies.  Aptamer can behave similar to 
antibody and also have several advantages. 
 
Aptamers are analogues of antibodies, have been reported with high affinities to their targets, having 
dissociation constants of low-picomolar to femtomolar level, comparable even better than antibodies.58 
Aptamers are more thermodynamically stable, having lower molecular weight. Moreover, the 
production of aptamer is not influenced by the physiological conditions as in antibody generation. 
Antibody generation relies on the in vivo parameters in animal body, whereby the recognition of the 
target by the antibody is strictly based on the suitable in vivo parameters. Size of the aptamer (usually 
~6,000 daltons) compared to antibodies (~150,000 daltons) have made aptamers object of intense 
interest in many target detection systems. Antibodies can only be raised against immunogenic targets 
in animals, while aptamers can be generated against virtually any target molecules. Once aptamer 
sequence is identified, large amounts of aptamers can be chemically synthesized, which confers no 
batch to batch variations. Aptamers can also be easily modified by adding extra sequences.  
 
Enhancement of the aptamer stability will make these aptamers more amenable to subsequent 
applications. Modification of the pyrimidines to 2’-amino, (2’-NH2), 2’-fluoro (2’-F) and purines to 2’-O-
methyl increase the stability of the RNA aptamer due to the less reactivity of these functional groups. 
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Some modification can be done in the initial library itself by 2’-ribose modification
which confers thermodynamic stability to the nucleic acids compared to the naturally occurring 
counter-parts.   In vitro generation aptamer has expanded to the several fields, such as molecular 
biology, molecular evolution, and molecular recognition to analyse the functional and structural 
aspects. Aptamers have been selected against a wide range of important targets irrespective of sizes, 
playing a vital role in the clinical front for therapy to prevent and treat disorders. As very efficient 
molecular probes, aptamers are widely used in a number of applications including biomedical, 
analytical, diagnostics and therapeutics by amalgamating with several methods to transduce the 
molecular recognition event of aptamer-target binding. Several aptamer-based drugs are now under 
different phases of clinical trials. The first therapeutic aptamer generated against the vascular 
endothelial growth factor (VEGF) for the treatment of neovascular age-related macular degeneration, 
was commercialized in 2004.59  The selected aptamers in the past have possessed significant 
(>10,000-fold) abilities to discriminate between closely related molecules.60,61 Aptamers can also 
distinguish between closely related viral sub-types and clotting factors.62,63 These discrimination 
abilities of aptamers can be used as the biorecognition elements, led to the development of high-
performance sensors. All other applications that use aptamers are highly connected 
with sensors for clinical diagnosis and imaging purposes in the front of nanotheranostics.  
 
1.5. Aptasensors  
After the invention of aptamers in the 90s, several aptamer-based sensors (so called 
“aptasensors”) were designed and these devices were used for several applications in interdisciplinary 
sciences. Applications of aptamers in the medical and immunodiagnostic fields have suggested that 
an aptasensor could be an alternate to other antibody-based sensors. Aptamers can be used to 
analyze target interactions, to generate inhibitors to be used for pharmacological purposes, to detect a 
target in a complex mixture, and for screening the drug library in medicinal chemistry. The aptamer can 
be a ligand when a mixture contains an analyte, whereas the aptamer is an analyte if it is in the 
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sample that is being analyzed. Usually, ligands are the interacting molecules immobilized on the 
sensor surface, can be done physically on the sensor surface or through pre-treated chemical linkage 
(Figure 1.7). The physical immobilization of molecules is mainly the result of electrostatic interaction, 
hydrogen bonding or van der Waals force. For the immobilization of aptamers through chemical 
linkages, any general strategy can be used because aptamers can be easily modified with linkers.  
 
Figure 1.7.  Ligand-analyte interactions on sensing surface.  The ligand can be immobilized by  
physical means (a) or through chemical linkers (b).  The scheme (b) is followed in most of the cases.  
 
Figure 1.8.  Classifications and applications of aptasensors.  Each sensor has different advantages.  
The choice of sensor is based on the purpose. 
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Aptamers can fold into versatile structures because they have basic stem-loop arrangements that form 
proper three-dimensional structures, in order to facilitate the formation of a complex with the target 
molecule and influence the target’s function.  For molecules with higher affinity, the aptasensor can be 
used without involving any labeling stategy, whereas for low-affinity molecules or a low abundance of 
target molecules, labeling with chemical tags or metal nanoparticles have been performed for signal 
enhancement. Aptasensors include electrochemical, electrical, chemiluminescence, fluorescence, 
quantum dot-based, colorimetric, reflection-based mass spectroscopic detections,13 play roles for 
several applications and are classified according to the detection mechanisms (Figure 1.8). 
 
1.6. Targets for aptasensor development 
 Aptamer can be generated against any size of molecules irrespective of sizes and these 
targets can be ions, vitamins, peptides, proteins, whole cell. In the present study, to evaluate the 
aptamer and protein interactions in the presence of potential PEG-b-polymers, two kinds of clinically 
relevant samples, namely FIX of human blood coagulating system, intact influenza virus and a surface 
membrane protein (Hemagglutinin-HA) of influenza virus were chosen. 
 
 1.6.1. Importance of human clotting factor IX (FIX) 
Blood coagulation process is a sequential interactive event that leads to the formation of a 
hemostatic plug following the injury and about 30 interacting proteins are involved in clotting process. 
Intrinsic and extrinsic are two pathways involved in the blood coagulation cascade. FIX is inactive 
unless activated by factor XIa in the intrinsic pathway or by factor VIIa and tissue factor complex in the 
extrinsic pathway. FIX has ability to interact with factors XIa, VIIIa, Va and factor VIIa/tissue factor 
complex and therefore, FIX is important in the overall coagulation process (Figure 1.9).64,65  Anti-FIX is 
shown to reduce bleeding risks in animal models, as the better reagent than currently using anti-
coagulant agent heparin.66  
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Figure 1.9. Human blood coagulating cascade.  Different clotting factors are involved and linked 
through cleavages and convertions.64 
 
Rusconi et al.67 found a highly potent anti-coagulant aptamer against human FIXa which can 
prolong the coagulation of plasma from human and animal species under in vitro condition. Rusconi et 
al.67 tested the effect of 2′-fluoropyrimidines modified stable anti-FIXa aptamer under in vitro and 
attached the PEG to the end of aptamer for in vivo analyses.  In addition, since aptamer is targeted on 
FIXa, it can reduce the bleeding risks and required minimal dose.  Based on their thorough analyses, 
they suggested that the anti-FIXa aptamer can block the cleavage of FX by the complex of FIXa-FVIIIa.  
Gopinath et al.65 found that the selected anti-FIXa aptamer has ability to bind FIX as well.  FIX is about 
55 kDa and the amino acid sequence (Figure 1.10a; GenBank Accession number CAA01607) and 
crystal structure (Figure 1.10b; Protein Data Bank code: 1RFN) are available in the data bank. 
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Anti-FIXa aptamer was thoroughly analysed by both in vitro and in vivo, based on these studies, 
probably anti-FIX aptamer may bind to the vicinity of EGF1 and EGF2 domains.65,67 
 
 
Figure 1.10.  Factor IX from human blood coagulating cascade. Amino acid sequence (a) and 
crystal structure (b) are displayed.  
 
Chapter 1: General Introduction 
 
 
29 
 
1.6.2. Influenza Virus 
Influenza viruses cause severe illness and infect mainly the upper respiratory tract regions such 
as nose, throat, bronchi and lungs. Influenza viruses has the diameter of about 80-120 nm and they 
are spherical or filamentous and enveloped.68  There are three major classess of influenza viruses 
namely, influenza A, B, and C. Influenza A is quite common, circulated among bird and mammalian, 
whereas influenza B is mainly found in human. Influenza C is less common may cause both illness 
and local epidemics.  These influenza viruses, especially influenza A caused severe death to the 
human population and posed several issues to human health and economy. In the past several 
decades, pandemic influenza emerged several times, the pandemic of 1918 with H1N1 swine flu had 
a huge impact caused the death rate to several millions worldwide.  For influenza infection, two major 
surface proteins glycoproteins HA and neuraminidase (NA) are play an important role.  Based on 
these proteins influenza A virus is classified according to their H number (for HA; 17 HA reported) or N 
number (for NA; 10 NA reported). There are two antigenic and genetic lineages of influenza B viruses, 
namely Yamagata and Victoria lineages.  Several new influenza strains are emerging continuously, 
H1N1 viral strain (pdm/2009) is the recently emerged and pandemic among humans a 
so called “swine flu”.  Other important subtype H5N1 from Influenza A virus is known as “bird flu”, 
which cause illness mainly in birds.  With poultry, mainly two subtypes such as H5 and H7 highly 
pathogenic, leads to 100% mortality.  Recent epidemiological evidence with the transmission of 
virulent new avian influenza A H7N9 was first reported in China by the World Health Organization on 
April 1, 2013.  The antigens, HA and NA on the virus are the dominant target for the host antibody 
response.  However, minor mutations in the amino acid sequences on these surface antigens occur 
frequently and this enables the viruses to evade the host immune system.  Continuation in this 
mutation process is called ‘antigenic drift’ which makes the yearly update and administration of 
influenza vaccines. HA is the major viral antigen for influenza infection required for membrane fusion 
with host cells to mediate at the early stages of influenza infection (Figure 1.11a,b).69  
Chapter 1: General Introduction 
 
 
30 
 
 
Figure 1.11.  Hemagglutinin from influenza virus. Amino acid sequence (a) and crystal structure (b) 
are displayed.  Structures of glycans from human and avian involved as the receptors for HA are 
shown.  
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During initial infection of influenza virus to the host cell, HA binds to sialic acid residues (glycans) 
namely Neu5Acα2,6Gal and Neu5Acα2,3Gal on  human and bird cells, respectively, with the 
assistance of three important amino acids (Figure 1.11a).  HA is a trimeric protein of about 
72 kDa, the amino acid sequence (Figure 1.11a; GenBank Accession number ACF54180) and crystal 
structure (Figure 1.11b;  Protein Data Bank code: 2VIU) are available in the data bank. 
 
1.7. Aptasensors demonstrated in the present study 
 With the assistance of aforementioned three types of PEG-b-polymers, high-performance 
aptasensors were developed in this study, by analyzing aptamer-FIX or aptamer-influenza virus 
interactions.  These sensing systems include, Evanescent-field-coupled Waveguide-mode (EFC-WM), 
Surface Plasmon  Resonance (SPR) and Surface Plasmon Fluorescence Spectroscopy (SPFS)  
(Figure 1.12). 
 
Figure 1.12. Sensing systems preferred to demonstrate the applications of PEG-b-polymers.  All these 
sensors are operates based on the principle of  Kretschmann configuration. 
 
1.7.1. Evanescent-field-coupled Waveguide-mode (EFC-WM) sensor 
The term "waveguide" is widely referred to as a structure capable to confine and guide 
electromagnetic waves.70  The state where the light is propagating while maintaining such light 
intensity distribution is called the waveguide-mode. Waveguide-mode sensor is designed with 
Kretschmann configuration, in which modifications in the dielectric environment near the waveguide-
mode sensor surfaces are detected with a high sensitivity by measuring changes in reflectivity. The 
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basic calculation for designing waveguide mode sensor was described70. The effective refractive index 
(N= Kx/K; Kx-progation constant) of a waveguide mode was given by the relation  
 
 Where, εM - dielectic constant at the metal; C-dielectic sample medium. In this configuration, the 
substrate is attached to a dielectric prism, and excitation light is used to irradiate the substrate through 
the prism at an appropriate incident angle.71 The first waveguide was with an optical system utilizes 
silicon oxide-titranium oxide.72  Planar and fiber optical waveguides are the general classes, based on 
the dimensions and light-guiding properties.  These two waveguides are further subdivided into single-
mode (only one light mode will be guided) and multimode (will allow several modes).73 The fabrication 
of waveguides was done by chemical vaporation methods and categorized as, the modification of 
substrate materials74 (by ion exchange in SiO2 or LiNbO3) and a waveguide layer is applied on top of a 
substrate material (usually with metal oxides or nitride).75  The typical materials for waveguide-mode 
sensors are SiO2, SiOxNy, Si3N4, TiO2, Ta2O5 and Nb2O5.
73 By utilizing a compact optical system of 
SPR sensors as a spectral readout, the EFC-WM sensor was reported.76  Evanescent field refers, 
when light is reflected, it penetrates into the medium that is reflecting the light.  Under total reflection 
condition, light penetrates into the medium with low refractive index to about one wavelength. In the 
waveguide-mode sensor device any kind of solid material that reflects light and optically isolates the 
waveguide from the substrate can be used as the reflecting layer. 
 
Figure 1.13. Sensing set-up of sensors. (a) waveguide mode and (b) Surface Plasmon Resonance 
mode.  Even though, the basic operating principles are same, both mode of sensor have different 
advantages. 
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The light from the lamp was guided to a collimator lens; and the collimated light radiated into a prism, 
coupling of prism in a waveguide-mode sensor is a simple and the light is coupled into the waveguide 
through the prism mounted on the waveguide-mode sensor surface and the angle of this coupling 
depending on the refractive index of the waveguide,73  where the incident angle was parallel to the 
bottom face of the prism.  As reported before, the prism can be made of SiO2 glass, and with the 
appropriate bottom angle.   Waveguide mode sensors are differing from the SPR-based sensors by 
the propagation of light on the sensing surface (Figure 1.13).   
 
1.7.2. Surface Plasmon Resonance (SPR) sensor 
A SPR-based aptasensor is one of the predominantly established sensors to analyze different 
aptamer-ligand interactions as a lable-free sensing system.77 SPR-based devises rely on optical 
method to measure the refractive index near a sensor surface.   SPR is known as the excitation of 
surface plasmon by monochromatic, electromagnetic waves and the polarized light at an interface 
between prism and metal coated surface surrounded by biological component and liquid environment. 
This event relies on the change of optical parameters, derived from the alteration of the layer closest 
to the sensitive surface in measuring the refractive index. Absorption of molecule on the receptor layer 
of biosensor changes the refractive index of the layer, reporting the event of binding, 
detectable and quantifiable in label free approach. The surface plasmons have a penetration on the 
substrate to a few hundred nanometers, causes the variations in the signal obtained in concomitant 
with spectral changes indicate that the biomolecular interactions occurred at the interface.78  Several 
SPR based biosensors were developed in a wide range of fields including biology, biomedicine and 
biochemistry.  SPR devices are based on the attenuated total reflection and categorized as 
conventional SPR, long-range SPR, coupled plasmon-waveguide resonance and 
waveguide-coupled SPR.  Even though, all these biosensors are dependent on SPR mode, their 
utilities are based on the exploitation in biomolecular analysis with higher specificity and sensitivity.79  
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 SPR biosensor is a preferred system of measuring different biochemical recognitions, including 
protein-peptide,80 protein-DNA,81 RNA-protein,82 cell-ligand,83 DNA hybridization,84 protein-protein,85 
protein-lipid,86 and assay developments,87 with real-time monitoring of complexes. Exhaustive surveys 
on SPR biosensor were carried out by Myszka and his colleague.88,89  Different SPR-based sensors 
are available depending on the placement of measurement chip, surface priming, composition of 
buffers, immobilization procedures and so on.  The development of mobile, compact, and cost-
effective sensing devices with potential for field applications were made possible with miniaturized 
SPR sensors, using the attenuated total reflection method as an alternative to laboratory-based SPR 
systems.90  A fiber optic SPR probe with wavelength interrogation was proposed and this sensor has a 
multimode optical fiber with locally exposed core and a thin Au film.91 A conventional prism coupled 
with a rectangular thin glass substrate with SPR active metal layer was described.92 Even though, 
several SPR based sensing systems have been developed in the past, SPR-based biacore system 
became more popular and routinely in use by several researchers,88,89 in the present study, 
experiments were performed using Biacore 3000.  
 
Biacore technology is an automated optical based system was created by a Sweden company 
founded in 1984 and this analytical system was launched in 1990 for biomolecular interactions and
expanded by introducing three systems, namely BIAlite, Biacore 1000 and Biacore 3000.  Recently, 
Biacore T100 system was released and it is suitable for high-throughput screening against different 
ligands by single assay set-up with higher sensitive advanced features (www.biacore.com and 
http://en.wikipedia.org).  Biacore detects refractive index changes in close proximity to a metal 
surface.93  Upon immobilization of ligands on the sensor’s surface the interfacial refractive index is 
altered, which will be detected and quantified by optical system as the changes in 
the angle of reflectance.94  Using biacore monitoring weak macromolecular interactions are possible 
that are not achieved by other sensors.  Biacore is suitable for analyses of wide range of bio-
molecules in real-time fashion as the label-free sensor and detected the lower concentrations.95  
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Various sensor chip-formats are constructed by either pre-immobilized ligands or modified by standard 
surface chemistries, to capture biomolecules.  Biacore system has advantages, such as preparation of 
bio-specific surface, analyses of kinetic constants, measurements of analytes’ concentrations and 
regeneration of the sensing surface for repeated use.  Most commonly used sensing surface is 
carboxymethyl-dextran material linked on Au surface to immobilize. Using Biacore, an assay was 
developed by using anti-IgE DNA aptamer, with a detection limit of 2 nM.96  On the other hand, 
Tombelli et al. (2005) demonstrated that Human immunodeficiency virus-1 (HIV-1) Tat protein was 
specifically captured by RNA aptamer, with a linear range of detection from 0 to 2.5 ppm. In addition to 
these common advantages, biacore system is also versatile for various purposes including high-
sensitive high-throughput analyses.   
 
1.7.3. Surface Plasmon Fluorescence Spectroscopy (SPFS)  
Some of the designed aptasensor strategies are associated with fluorescence-tagged, by 
availing signaling by a single fluorophore, fluorophore-quencher pair, structure-switching, and 
fluorogenic reaction.97 The fluorescence labeling of an aptamer at its end can be done using 
fluorescent tags. Fluorescence-based assays generated for thrombin binding aptamers were 
summarized and shown the detection limit of sub-picomolar levels.97,98  SPFS is one of the sensors
can be measured the interactions of fluorescent molecules, was implemented first in 1991, with a SPR 
based fluoroimmunoassay for Human Chorionic Gonadotrophin (HCG) and attained the limit of 
detection to <240 pM HCG in serum.100  Later, SPFS was potentially re-established by Liebermann, 
and Knoll101 with the  setup based on angular modulation of SPR is combined with fluorescence 
spectroscopy detection for the quantitative and in situ discrimination of single-nucleotide 
mismatches in oligonucleotide double strands.  SPFS is based on ehhanced electromagnetic field of a 
surface plasmon for the excitation of surface-confined fluorophores.  Upon interaction of biomolecules 
the interfacial index changes and the fluorescence signals in real time fashion gives an output signal. 
The slight angular displacement between the minimum angle in the reflectivity scan and the 
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fluorescence intensity peak position is a consequence of the resonant excitation of the surface 
plasmon waves interfering with the directly reflected laser beam: the re-radiated and out-coupled 
plasmon light destructively interferes with the plane wave of the laser reflected at the prism/metal 
interface provided their relative phase shift corresponds to π or 180º.102 The fluorescence signal 
occurs upon the resonant coupling to surface plasmons can be measured as a function of time, 
enables the monitoring kinetics of biomolecular reactions. The implementation of SPFS to SPR 
biosensors found to increase the sensitivity by several orders of magnitude and overviewed in 
detail.103 Like waveguide and SPR, in most cases, the Kretschmann configuration will be the coupling 
scheme of choice for SPFS because the evanescent character of  the surface wave being excited 
from the back of the prism. The alternative scheme for surface plasmon excitation by laser light based 
on a surface grating structure offers a number of advantages for biosensing in general and for SPFS.  
The strategies generated based on the SPFS are grating coupling for SPFS, long-range surface 
plasmons for SPFS, fluorescence imaging and color multiplexing and so on.104 The SPFS is 
equivalently widespread as immunosensor for analyzing antigen and antibody interactions on the 
sensor surface104. It was elucidated novel applications of SPFS in monitoring multicomponent 
adsorption from the aqueous phase, using simultaneous information from SPR and fluorescence.105 
 
The major challenges, especially in the bioscientific field are to elucidate the functions of 
biologically relevant molecules.  Hence, developing effective bio-recognition sensors are mandatory 
for monitoring biomolecular interactions in real time fashion.  Several successes have been reported in 
the past using different sensing systems owing to its convenience for the analyses of chemical and 
biological compounds.  The applications of this sensor development include, medical diagnostics, 
environmental monitoring, food safety and security as reviewed before (Homola, 
2008).   Keeping all these facts discussed above, the present study was launched for the application 
of PEG-b-polymers on different sensing surfaces as described below with the chapters 2,3 and 4. 
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Chapter 2: High-performance Evanescent-field-coupled Waveguide-mode biosensor for 
detection of Factor IX uses PEG-b-PAAc on SiO2 surface and N6-PEG on Gold 
Nanoparticle.
Chapter 3: Co-immobilization of PEG-b-PAMA and N6-PEG promotes non-biofouling on Au 
surface of Surface Plasmon Resonance biosensor for detection of FIX in human 
plasma. 
Chapter 4: Generation of anti-influenza aptamers for sensing applications on PEG-b-
PAAc/fluorescent hybridized surface of Surface Plasmon Fluorescence 
Spectroscopy.  
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2.1. Abstract 
An evanescent-field–coupled waveguide-mode (EFC-WM) sensor utilizes monolithic 
SiO2/Si/SiO2 sensing plates having a multilayer structure and is used to evaluate a blocking agent 
comprising poly(ethylene glycol)-based block copolymers (PEG-b-polymer). Factor IX (FIX) protein 
was detected using its aptamer, viz., FIX was immobilized on a glutaraldehyde (Glu)-modified silica 
surface, and then treated with a biotinylated aptamer. The quantitative analysis of FIX was carried out 
using streptavidin-conjugated gold nanoparticles (SA-GNPs). The blocking polymer, poly(ethylene 
glycol)-b-poly(acrylic acid) (PEG-b-PAAc), was found to mask unreacted amine and Glu moieties on 
the SiO2 surface, and it completely prevented the non-specific binding of SA-GNPs. By exploiting the 
strong blocking effect of PEG-b-PAAc, the author achieved high ligand–analyte interaction sensitivity 
(sensitive down to 100 pM). To improve the sensitivity further, the author also used 
pentaethylenehexamine-terminated PEG (N6-PEG) on gold nanoparticle (GNP). The improvement in 
sensitivity was found to be 1000-fold (to 100 fM), which was substantiated by the observation of higher 
number of GNPs on the sensing surface in the results of scanning electron microscopic examination. 
Based on the competition assay of free biotin premixed with SA-GNPs, it was concluded that some 
active biotin-binding sites on the streptavidin were blocked by N6-PEG，which improved the binding 
ability to the biotinylated sensing surface. An optimum number of binding sites on the SA-GNPs might 
improve their binding affinity. The strategy shown with dual polymers, viz., blocking of the sensor chip 
surface and coating of SA-GNPs, is recommended for developing sensors with higher sensitivity and 
reliability. Selective binding of the aptamer to a very small amount of FIX in the mixed sample 
containing FXIa and FVIIa, or albumin, makes this the optimal strategy for detecting a FIX deficiency 
in human blood samples. 
 
2.2. Introduction 
The development of nanobiosensors that may be used to analyze biomolecular recognition 
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elements is currently one of the most important targets in the field of medical diagnosis. A useful 
biosensing system requires some key characteristics such as specificity and sensitivity. It can be 
accomplished by the correct orientation of the immobilized biomolecules in order to expose to receive 
the analyte on the sensing surface.1  Natural polymers are used in several instances to suppress the 
non-specific interaction of ligand and analyte.2  However, the efficiency of the natural polymers 
(albumin, casein, and dextran) are not completely satisfactory. Natural polymers derived from animals 
may contain disease-causing components. The blocking performance of natural polymer is different 
between the lots. Synthetic polymers, by contrast, are easily reproducible and contain no contagions. 
Thus, high-performance surface modification techniques using synthetic polymers are highly 
anticipated. With synthetic PEG tethered-chain surface, there were demonstration for high-
performance sensing and it shows high resistance to biofouling.3-11 For effective immobilization of 
PEG-derivatives on substrate surfaces, suitable anchoring strategies must be designed using specific 
interactions such as hydrophobic or electrostatic interactions or covalent conjugation. PEG-b-
polycations, PEG-b-polyanions, and PEG-b-hydrophobic polymers are the versatile materials, can be 
used on different sensing surface and a typical example is the application of PEG-b-PAAc on Y2O3 
nanoparticles.5 PEG-b-polyamine was used for the modification of Au surfaces for specific 
biorecognition.6,7 The coordination of the lone pair of the amino groups to the gold surface is involved 
in this case. 
Improvement in sensor performance is another target in the development of high-performance 
sensor systems. Herein, the author has chosen evanescent-field-coupled waveguide-mode (EFC-WM) 
monolithic sensing plates having SiO2 surface
12 to demonstrate the capability of PEG-b-polymers as 
the blocking and specificity-enhancing agents. At present, SiO2 is commonly used as the sensing 
surface in the development of high-sensitivity systems.13-23 The great advantage of the waveguide 
sensor is that higher sensitivity can easily be obtained by metal-nanoparticle labeling.22 The 
waveguide sensor system that we used was similar to that of a surface plasmon resonance (SPR) 
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system, and the difference was that the mode used for measurement is a waveguide mode rather than 
a surface mode. Unless otherwise stated, the design and configuration of the waveguide sensor is 
based on the principle of Kretschmann, a well-known scheme for the light irradiation of the thin film 
attached to the prism.13,21-25 Biomolecular interactions can be monitored by measuring changes in the 
local index of refraction upon adsorption of target molecules onto the surface of the waveguide-mode 
sensor.  EFC-WM sensor has advantages of SPR sensor makes the preference of EFC-WM sensor in 
this study (Table 2.1). 
 
Table 2.1. Advantages of waveguide mode over SPR- mode sensors 
 
The sensitivity of EFC-WM was enhanced by nano-perforations in the waveguide layer and increasing 
the size of the nanoholes promotes the concomitant improvement in the sensitivity.26 In addition, 
labeling analytes with colored materials or GNP-conjugates were also an effective method for 
enhancing the signals. Using these strategies, the detection of molecules of various sizes has been 
demonstrated using biomolecular interactions and assembly processes. EFC-WM sensor was 
proposed as an aptasensor with different surface modifications, surfaces with nano-perforations, and a 
color-labeling technique.27 Sizes of EFC-WM can be minimized into to smaller sizes (Figure 2.1a) and 
the spectral changes are depends on the molecules to be used (Figure 2.1b). 
 
The objective of this work is to establish a high-performance biosensor by using the EFC-WM 
sensor, and comprising PEG-based blocking agents for both sensor surface and nanoparticles.
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Human coagulating factor IX (FIX) was selected as a model analyte because it has extremely low 
availability in vivo and important to detect for blood coagulation analysis.  A stable RNA-aptamer 
generated against FIX was used as the ligand28 and demonstrated favorable properties with regards to 
highlighting the potential characteristics of the preferred PEG-derived polymers. 
 
Figure 2.1. EFC-WM sensor. (a) minimized set-up (b) patterns of spectral changes with different 
samples. 
 
2.3. Experimental section 
2.3.1. Reagents and biomolecules  
3-Aminopropyltriethoxysilane (APTES) was purchased from Sigma–Aldrich (Tokyo, Japan). 
Glutaraldehyde, biotin, and precast gradient polyacrylamide gel were procured from Wako Chemicals 
(Osaka, Japan). Gold nanoparticles (GNPs) conjugated with streptavidin (40 nm; 15-OD) were from 
BioAssay Works (MD, USA). The shorter oligonucleic acid (dT20) conjugated with biotin at the 5′-end 
and the other oligonucleic acids were synthesized commercially. FIX was purchased from American 
Diagnostica (Stamford, CT). Pre-casted gradient polyacrylamide pre-cast gels was purchased from 
Wako chemicals (Osaka, Japan). Horse radish peroxidase-conjugated anti-mouse immunoglobulin G 
was purchased from Promega, Medison USA. Clear Blot membrane-P and nitrocellulose membranes 
Chapter 2:  High-performance Evanescent-field-coupled Waveguide-mode  Biosensor for Detection of Factor IX 
Uses PEG-b-PAAc on SiO2 Surface and N6-PEG on Gold Nanoparticle 
47 
 
 
were purchased from ATTO (Tokyo, Japan) and Millipore (MA, USA), respectively. Triton, Tween-20, 
and sodium dodecyl sulfate (SDS) were from Wako Chemicals (Osaka, Japan). The enhanced 
chemiluminescence kit was from Amersham Pharmacia Biotech (PA, USA). PEG-b-PAAc was from 
General Science Corporation (Japan). N6-PEG was kindly provided by JSR (Tokyo, Japan). All 
samples were stored according to the suppliers’ recommendations. 
 
2.3.2. Enzymatic synthesis of aptamer 
A stable 34-mer (2′-fluoro-modified) RNA-aptamer, which was previously reported by Rusconi et 
al.28 was prepared and its ability to bind FIX or FIXa was verified.28,29 The aptamer was synthesized on 
a synthetic DNA template by enzymatic reaction (in vitro transcription) using T7 RNA polymerase. The 
T7 promoter region (letters are highlighted in italics) was maintained at the 5′-end of the aptamer to 
generate the RNA molecules. The template, 5′-
AGTAATACGACTCACTATAGGGATGGGGACTATACCGCGTAATGCTG-3′ was used to prepare the 
double-stranded DNA. A polymerase chain reaction (PCR) was carried out using the above DNA 
template and amplified using appropriate primers (5′-AGTAATACGACTCACTATAGG-3′ [forward] and 
5′-(T)24ATGGGGAGGCAGCATTACGCGGTATA-3′ [reverse]) using 2X PrimeSTAR Max DNA 
Polymerase, from Takara Bio Inc., (Japan). Twenty PCR cycles were completed at 94 °C for 70 s, 
55 °C for 50 s, and 72 °C for 70 s. After proper PCR amplification, the PCR product was precipitated in 
ethanol and used for RNA preparation by in vitro T7 transcription. Transcription was carried out at 
37 °C overnight, using a DuraScribe transcription kit (Epicentre Biotechnologies, USA). The products 
were treated with 2 U of DNase I (RNase free) for 20 min at 37 °C, to remove the residual template 
DNA, and the reaction was terminated by adding an equal volume of 2x urea buffer (7 M urea, 50 mM 
EDTA [ethylenediaminetetraacetic acid], 90 mM tris-borate containing 0.05% bromophenol blue). 
Afterwards, the reaction mixture was heated at 90 °C for 2 min and loaded onto a 12% polyacrylamide 
gel containing 7 M urea to fractionate. The RNA band was visualized under UV shadow and extracted 
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from the excised gel-piece by using the crush-and-soak method.28 The RNAs were precipitated in 
ethanol and dried under vacuum, re-dissolved in RNase-free water, and the concentration was 
measured spectrophotometrically at 260 nm. Using the following DNA template, 5′-
AGTAATACGACTCACTATAGGGTACCCCTGATATGGCGCATTACGAC-3′ (T7 promoter region 
highlighted in italics), the complementary FIX aptamer was synthesized as described above by the 
same T7 forward primer and the reverse primer 5′-(T)24TACCCCTCCGTCGTAATGCGCCATAT-3′, for 
negative reaction. 
 
2.3.3. Setup of the EFC-WM sensor 
The evanescent-field-coupled waveguide-mode (EFC-WM) sensor consists of a multilayer sensing 
plate comprising a dielectric waveguide, a high-refractive index layer, and a glass substrate.12 The 
sensing plate, which is illuminated using the Kretschmann configuration, operates as a sensor that is 
capable of detecting modifications in the dielectric environment near the waveguide surface by 
measuring changes in reflectivity. The optical setup is shown in Figure 2.2a. A  halogen lamp was used 
as a light source. The light from the lamp was guided to a collimator lens and a prism was irradiated 
with the collimated light; the incident angle of the light was parallel to the bottom face of the prism. 
Then, the monolithic sensing plate placed on the bottom of a prism was illuminated and a spectrum of 
the reflected light was detected using a spectrophotometer (Ocean Optics, Florida, USA). The prism 
was made of SiO2 glass and its bottom angle was 38°. The monolithic sensing plate consisted of a 
SiO2 glass substrate, a single crystalline Si layer, and a thermally grown SiO2 waveguide layer, where 
the thicknesses of the layers are 45 nm and 360 nm, respectively. The fabrication method of the 
sensing plate is described in elsewhere (Figure 2.2b).12 The optical measurements in this study were 
taken around 520 nm to show a dip in reflectance, which corresponds to the optical absorption of 
GNPs. If GNPs are attached to the waveguide surface, the dip will be deepened by the optical 
absorption of the GNPs.22 
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2.3.4. Surface functionalization on SiO2-sensing plate 
Sensor chips were initially treated with an alkali solution for 30 min and washed thoroughly with 
a copious volume of buffer (10 mM HEPES [4-{2-Hydroxyethyl}-1-piperazineethanesulfonic acid]-KOH, 
150 mM NaCl [pH 7.4]) to remove the free hydroxide ions, and the surface was dried.  
 
Figure 2.2. (a) Schematic diagram of the waveguide-mode sensing system. A prism, a sensing plate, 
and other supports are shown. Light source is from halogen lamp and light was detected using a 
spectrophotometer. FIX and its aptamer are attached on the surface of the top SiO2 layer. (b) 
fabrication method of the sensing plate (c) Schematic of chemical surface modifications of the SiO2 
layer of the sensing plate for FIX and aptamer interactions. Glu was attached to the amine-modified 
surfaces, followed by FIX protein immobilization. The aptamer ending with A24 was attached and then 
biotin with dT20 was allowed to react. SA-GNPs (40 nm) were used as a label. Sequences of the 
aptamer extended at the 3′-end are shown in the dotted box. (d) Spectrum shows the stable 
attachment of Glu on the amine-modified surface. Black, blue and red spectra indicate buffer only,  Glu 
attachment and FIX, respectively. Chips with the ability to measure the shifts around 630 nm 
were used. A red shift was observed by the attachment of Glu, because the transparent material, Glu, 
was attached on the surface.12 There were no changes in the red spectrum after several washing 
steps, indicating that Glu was stably attached on the amine-modified surface. 
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Then further modification was carried out by immersion in a 0.5% (v/v) ethanol solution of APTES for 
24 h. The amine group-functionalized surface of the SiO2 waveguide layer was rinsed with ethanol and 
dried in a stream of nitrogen gas. The amine-functionalized SiO2 surface was treated with a 2.5% 
solution of aqueous Glu for 3 h at room temperature to form an aldehyde-activated surface. After 
incubation, the surface was washed thoroughly with the HEPES buffer. The Glu-activated surface was 
made available for the covalent attachment of FIX, and then the remaining free amine sites were 
blocked by the introduction of PEG-b-PAAc. Anti-FIX aptamer extended with dA24 at the 3′-end was 
permitted to react with the FIX on the surface. The free end of the aptamer with dA24 was duplexed 
with biotin-dT20. Finally, the biotin–streptavidin interactions were monitored by immobilizing the SA-
GNPs in the presence or absence of N6-PEG (Figure 2.2c). The sensor surface was functionalized by 
Glu, which has strong affinity for amine-modified SiO2 surfaces; the spectrum shown in figure 2.2d 
demonstrates that stable attachment of Glu was achieved after a long incubation and several 
washings. Optical density (OD) of the SA-GNP solution was measured and the dilutions were 
prepared using 10 mM HEPES (pH 7.4) to obtain 1 OD SA-GNP solution from the original stock 
supplied. Each reaction was performed for 30 min on the sensor chip, after which the sensing surface 
was thoroughly washed 3 times with 300 µL of HEPES buffer. In order to maintain the stability of the 
interaction between FIX and the aptamer, 2 mM CaCl2 was added to the buffering solution, as 
previously recommended.28 
 
2.3.5. Determination of Limit of detection 
To determine the sensitivity of detection of FIX on the waveguide-mode sensor, the author 
performed experiments with aptamer and protein titrations using single (PEG-b-PAAc) and dual 
polymers (PEG- b-PAAc and N6-PEG). Surface modifications for all experiments were carried out as 
described above. Aptamer titrations were carried out after modification with PEG-b-PAAc of the Glu-
modified surface of SiO2. For this titration, the author kept the FIX (250 nM) and PEG-b-PAAc 
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concentrations (4 mg/mL) constant and titrated using different concentrations of aptamer (10 pM to 
200 nM). After attaching the aptamer as described above, the DNA ends with biotin
was complemented. Spectral changes were monitored by using 1 OD of SA-GNPs. Similar titration 
was also carried out with the addition of N6-PEG (0.5 mg/mL) to the 1 OD of SA-GNPs. To optimize 
the sensitivity limit of FIX, the author also performed the protein titration at 100 fM to 250 nM, keeping 
the aptamer (100 nM) and PEG-b-PAAc (4 mg/mL) concentrations constant. Limit of detection is 
calculated with the value 3 times higher resonance angle than the control experiment.  Measurements 
were carried out with or without addition of N6-PEG (0.5 mg/mL) on SA-GNPs. 
 
2.3.6. Biotin-streptavidin competitive assay 
The author carried out the competition assays with the addition of different concentrations of free 
biotin to SA-GNPs. For this assay, the surface treatment and chemical modifications of the sensing 
surface were the same as described above. Biotin was used as a competitor at concentrations of 0.1 
fM to 1000 fM. The biotin concentration was varied whilst maintaining a constant SA-GNP optical 
density (1 OD) and titrated on a biotin-immobilized sensing surface with constant aptamer 
concentration. 
 
2.3.7. Scanning electron microscopy (SEM)-Nanoscale Imaging 
To increase the sensitivity of the specific biomolecular interaction described above, the author 
mixed N6-PEG with SA-GNPs. To visually confirm the effect of the N6-PEG on the sensing 
performance, the author carried out microscopic analyses with field emission scanning electron 
microscopy (SEM; JEOL, JSM-6340F) on the SA-GNP surfaces in the presence and absence of N6-
PEG. Surface modifications were as described in Fig. 2.2c. N6-PEG was premixed with SA-GNPs 
before being attached to the biotinylated sensing surface. The attachment of GNPs was observed 
using SEM. SEM measurements were carried out with 5 kV acceleration and 10 µA emission.
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Images were captured at a magnification of 10000. All SEM observations were performed at a GNP-
streptavidin conjugate optical density of one, as described above. 
 
2.3.8. Selective and specific binding of aptamer with FIX on the surface  
For selective binding which mimics a similar situation in the blood samples, experiments with 
mixed clotting proteins were carried out. Different concentrations of FIX, representing concentrations 
lower than the saturation points from the above assays with dual polymers, were considered. For this 
assay the author used a protein mixture (FIX, FXIa, and FVIIa); the author kept FXIa and FVIIa 
concentrations constant and titrated the binding of FIX at concentrations of 100 fM to 1 nM. All other 
surface chemical modifications and detection strategies were the same as those described above. The 
selective binding study was also performed in the presence of 84 nM of albumin with dose-dependent 
FIX concentrations from 100 fM to 1 nM. These mixtures were tested against a constant aptamer 
concentration (100 nM). 
 
2.4. Results and Discussion 
An improvement in biofouling resistance is necessary in biosensor development and 
biomolecular recognition. The steps of the sensing strategy are as follows: (i) FIX was applied to the 
Glu-modified SiO2 surface to mimic blood proteins; (ii) the specific interaction of aptamer-A24 with the 
target protein (FIX in this case) takes place on the surface; (iii) the hybridization of biotinyl-dT20 to the 
aptamer-A24 takes place; (vi) contact is made with GNPs that are surface-modified with streptavidin; 
and (v) the absorption is measured using the EFC-WM sensor. During these steps, the issue of non-
specific interactions of aptamer-A24 and GNPs is important with regard to suppressing background 
signals. In this study, the author has utilized 2 kinds of synthesized polymer derived from PEG, viz., 
PEG-b-PAAc and N6-PEG, in order to create high-performance sensing surfaces. The 
idea was to achieve the most effective blocking of both the sensor chip and the surfaces of the GNPs
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 using PEG-b-PAAc and N6-PEG. With the assistance of these blocking polymers, the author has
analyzed human coagulating FIX. An aptamer against FIX was used to improve specific sensing. This 
2′-fluoropyrimidine-modified stable aptamer, which binds FIXa with high affinity and specificity,28 binds 
FIX with equal efficiency.29 FIX used in this study has high purity and migrates as a single prominent 
protein under sodium dodecyl sulfate poly(acrylamide) gel electrophoresis (SDS-PAGE) (Figure 2.3a). 
The aptamer prepared by the enzymatic reaction (transcription) is a 58-mer, and contains 34-
nucleotides at its 5′-end that specifically bind with human FIX (Figure 2.3b). The non-specific 
attachments of SA-GNP were found to occur on amine- and Glu-modified surfaces. The potential 
blocking effect of PEG-b-PAAc on these surfaces was compared with that of ethanolamine, which is a 
common blocking agent for sensing surfaces. Further, the improvement in the sensitivity was 
evaluated following the additional usage of N6-PEG on GNPs. 
 
 
Figure 2.3. FIX and aptamer. (a) Purity of FIX on SDS-PAGE. The FIX band was migrated at ~55,000 
daltons. 3 µg of FIX was loaded. (b) Schematic diagram for the duplex formation of FIX aptamer with 
extended 3´end  (A24 ) and biotin-dT20.  Spacer region was created for flexibility.  Figure inset is shown 
for mobility of anti-FIX aptamer without (1) and with (2) poly-A tail on 4% agarose gel. 
 
Chapter 2:  High-performance Evanescent-field-coupled Waveguide-mode  Biosensor for Detection of Factor IX 
Uses PEG-b-PAAc on SiO2 Surface and N6-PEG on Gold Nanoparticle 
54 
 
 
2.4.1. Influence of ethanolamine or PEG-b-PAAc on FIX recognition of chemically functionalized 
SiO2 surface 
 
Before optimization of the sensing of FIX by the present system, the author confirmed that the 
system works properly by using ethanolamine and PEG-b-PAAc as blocking agents. After FIX solution 
was contacted with the Glu-treated sensor chip, the biotinylated aptamer was reacted in the presence 
of a buffering agent containing CaCl2, which is necessary for these ligand-analyte interactions.
28  
 
Figure 2.4. Aptamer and FIX interaction using ethanolamine or PEG-b-PAAc as the blocking material. 
(a) Specific reaction using ethanolamine (b) non-specific reaction using ethanolamine (c) specific 
reaction using PEG-b-PAAc (d) non-specific reaction using PEG-b-PAAc. Black and red 
curves are the spectra before and after the attachment of SA-GNP, respectively. Arrows indicate the 
direction of changes in the spectrum. 
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On this biotin-exposed surface, the author immobilized the SA-GNPs, which were preferably 40 nm in 
size and could enhance the spectral signaling to a large degree at 520 nm (suitable for Au). 
Biotinylated complementary aptamer sequence was used for the control experiment.  Figure 2.4 
clearly demonstrates the spectral changes resulting from the SA-GNP–biotin interaction on the 
waveguide sensor surfaces. However, in the case of the ethanolamine-treated sensing surfaces, 
significant spectral changes were recognized both in the specific adsorption (Figure 2.4a) and in the 
control experiment (Figure 2.4b).This result indicates that the ethanolamine-modified surfaces could 
not prevent the non-specific interaction between SA-GNPs and the waveguide sensor surfaces. In the 
case of sensing surfaces using PEG-b-PAAc as a blocking agent, the author could clearly see the 
difference of the spectral changes in the specific aptamer-treated surface (Figure 2.4c), and the 
background signal was completely suppressed (Figure 2.4d). In order to significantly improve the 
colloidal stability and non-fouling character of SA-GNPs, the author used N6-PEG as the blocking 
agent. Non-specific absorptions of SA-GNPs with and without N6-PEG were investigated on a PEG-b-
PAAc-immobilized sensor chip surface using the EFC-WM sensor. Interestingly, no signal change
was observed regardless of N6-PEG blocking, as shown in Figure 2.5. Complete protection of sensor 
chip surface by PEG-b-PAAc might prevent non-specific interaction of SA-GNPs even without N6-PEG 
blocking. 
 
To check the required amount of PEG-b-PAAc, the author titrated the PEG-b-PAAc 
concentrations from 0.5 mg/mL.  As determined in the above section, 4 mg/mL of PEG-b-PAAc was 
desired as the highest concentration.  Initially, with lower concentration (0.5 mg/mL) of PEG-b-PAAc, 
interactions of FIX and complementary aptamer sequence were checked. A spectral change in the 
waveguide sensor system was found to have non-specificity and it was with the reflectivity changes of 
30%. With gradually increasing concentration of PEG-b-PAAc, the non-specificity was reduced 
correspondingly.  With the PEG-b-PAAc concentrations of 1 and 2 mg/mL the non-specific spectral 
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changes were measured as 20 and 5%, respectively. No spectral changes were found at the 
concentration of 4 mg/mL of PEG-b-PAAc, indicates under this condition PEG-b-PAAc was exclusively 
favored the specific interactions (Figure 2.5). 
 
Figure 2.5. Control experiments with complementary sequences of FIX aptamer using different PEG-
b-PAAc concentrations. Black and red spectrums indicate only buffer and attachment of streptavidin 
conjugated GNP, respectively. Predicted secondary structure with complementary sequences is shown.  
Arrows indicate the direction of changes in the spectrum.  By the addition of N6-PEG (0.5 mg/mL) with 
SA-GNP, the spectrum remains same. 4 mg/mL of PEG-b-PAAc is sufficient for controlling non-
specificity. 
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2.4.2. PEG-b-PAAc prevents needless binding on amine and Glu surfaces 
To check the origin of non-specificity, initially it was aimed to immobilize SA-GNPs directly on the 
amine surfaces. SA-GNPs have shown higher spectral changes as non-specific binding on amine 
surface (Figure 2.6a).     
 
Figure 2.6. PEG-b-PAAc prevents the non-specific binding of SA-GNP on the amine and Glu surfaces. 
(a) Binding of SA-GNP on the amine surfaces. Arrow indicates the direction of changes in the 
spectrum. (b) PEG-b-PAAc prevents the binding of SA-GNP on the amine surfaces. Schematics are 
shown. Black and red spectrums indicate only the buffer and attachment of the SA-GNP, respectively. 
(c) Spectrum shows complete blocking of amine surfaces by PEG-b-PAAc. No spectral change was 
noticed. Black and red spectrums indicate only buffer and attachment of FIX, respectively. (d) 
Spectrum shows the complete coverage of Glu surface by PEG-b-PAAc. Glu was attached on the 
amine surface and protein was passed and FIX could not bind.  Black and red spectrums indicate only 
buffer and attachment of FIX, respectively. Schematics are shown for each experiment. Chips suitable 
to measure the shifts around 630 nm were used.  
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This non-specific attachment is due to the electrostatic interactions occurred on amine-surface as 
suggested for other surfaces.1 To sort out this issue, PEG-b-PAAc with concentration of 4 mg/mL was 
introduced on the amine surface, and then SA-GNPs were attached.  Non-specific adsorption was 
completely quenched in the presence of PEG-b-PAAc (Figure 2.6b). Non-specific binding of negative-
charged SA-GNPs, could be due to the consequence of attraction with the positively charged amino 
surfaces and it was protected by blocking with negative charged PEG-b-PAAc.  This reaction imitates 
the previous report showing negatively charged anionic polymer (PEG-b-PAAc) binds on the positively 
charged rare earth ion-doped Y2O3 nanoparticles surfaces.
5  Based on our results, it was predicted 
that the bio-fouling occurred mainly because of the available free amine surfaces on the sensing 
surface. 
 
To find non-specific binding of FIX on the amine, the author immobilized PEG-b-PAAc on amine-
modified surface. Then reaction made with Glu followed by protein as the regular procedure designed 
for our experiments.  When the author immobilized the protein on the Glu attached sensing surface, 
the author could not observe any changes in the spectrum by the waveguide mode sensor, even after 
a prolonged incubation time (Figure 2.6c).  This result supports the above conclusion as PEG-b-PAAc 
can block the amine surface and it also inferred that 4 mg/mL of PEG-b-PAAc concentration could 
completely block the amine surface.  The author were also keen to find the binding ability of PEG-b-
PAAc on the Glu surface, for this notion, tried in another way in that PEG-b-PAAc was used after 
treating the sensing plate with Glu, but before treat with protein.  There is no significant binding was 
recognized by the waveguide sensing system, as PEG-b-PAAc blocked the binding of protein on Glu 
surfaces (Figure 2.6d). In this case, PEG-b-PAAc masked the Glu-surfaces and also binds to the 
remaining amine surfaces from silane coupling reaction which is escaped from the Glu reaction. 
Previously, the effect of PEG-b-PAAc was also evidenced on other surface (rare earth ion-doped Y2O3 
nanoparticles) and found to reduce the non-specific interactions of streptavidin and biotin.5 It seems, 
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PEG-b-PAAc has ability to mask different surfaces, as the potential common blocking agent. 
 
Figure 2.7. Aptamer titrations against constant FIX (250 nM). Concentrations of other biomolecules 
were kept constant. Graphical representation of comparative analyses for the PEGs. Reflectivity 
changes are shown for: (a) constant FIX (250 nM) against different concentrations of aptamers in the 
presence of PEG-b-PAAc; (b) constant aptamer (100 nM) against different concentrations of FIX in the 
presence of PEG-b-PAAc; (c) constant FIX (250 nM) against different concentrations of aptamers in 
the presence of PEG-b-PAAc on the sensing plate and N6-PEG on the SA-GNP; and (d) constant 
aptamer (100 nM) against different concentrations of FIX in the presence of PEG-b-PAAc on the 
sensing plate and N6-PEG on the SA-GNP. Fitting curves are shown as figure insets. 
 
2.4.3. Determination of detection limit using single and dual PEG-polymers 
The detection limit of FIX was investigated using PEG-b-PAAc. Initially, the aptamer 
concentration necessary for the saturation level was accessed by using different aptamer 
concentrations against constant FIX. The author found the minimal specific interaction at 100 pM of 
aptamer, which showed a reflectivity change of 6%.  Results obtained from FIX titrations against 
constant aptamer and aptamer titrations against constant FIX were shown in Figure 2.7a-d. Aptamer 
concentration higher than 100 
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nM showed constant changes in the spectrum indicates the attainment of saturation (Figure 2.7a; 
spectra are shown in Figure 2.8).  
 
Figure 2.8. Spectra of aptamer titrations against constant FIX (250 nM). Aptamer titers were shown 
from higher concentration to lower concentration. Concentrations of other biomolecules were kept 
constant. Black and red spectra curves are the spectra before and after the attachment of SA-GNP, 
respectively. Arrows indicate the direction of changes in the spectrum. 
 
Using this suitable aptamer concentration, the detetion limitl to FIX was investigated. Figure 2.7b 
shows the detection of FIX under a constant aptamer concentration of 100 nM; the FIX was detected 
at 100 pM as a 6% reflectivity change (spectra are shown in figure 2.9).  It was previously reported 
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that the densely packed PEG chains surrounding an antibody immobilized on a sensor chip surface 
improve its effectiveness.1,4,8 This might be one of the reasons that our system demonstrated a 100 
pM level of sensitivity.  With increasing FIX concentration, the signal changes were increased 
concomitantly. Similar titrations using saturated levels of aptamer (Figure 2.7c; Figure 2.10) against 
FIX-dose dependency were also carried out using SA-GNP with N6-PEG.  
 
Figure 2.9. FIX titration with different concentrations against constant aptamer (100 nM). FIX titer 
were shown with higher concentration to lower concentration. Concentrations of other biomolecules 
are constant.  Black and red spectrums indicate only buffer and attachment of the streptavidin 
conjugated GNP, respectively. Arrows indicate the direction of changes in the spectrum. 
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Figure 2.10.  Aptamer titrations with different concentrations against constant FIX (250 nM). Aptamer 
titers were shown with higher concentration to lower concentration. Concentrations of other 
biomolecules are constant.  Black and red spectrums indicate only buffer and attachment of 
streptavidin conjugated GNP, respectively. SA-GNP used with 0.5 mg/mL of N6-PEG.  Arrows indicate 
the direction of changes in the spectrum. 
 
Figure 2.7d show the detection limit of FIX using PEG-b-PAAc on the sensor chip surface and N6-
PEG on the SA-GNP (spectra are shown in Figure 2.11).  As can be seen in the figure, a large 
increase in the detection limit was observed when the author used both PEG-b-PAAc and N6-PEG. It 
is interesting to note that N6-PEG immobilized on SA-GNP surfaces influenced sensing ability though 
it did not influence suppression of non-specific binding on the sensor chip.  At the sensitivity 
concentration determined in the earlier experiment with only PEG-b-PAAc (100 pM), addition of N6-
PEG showed 3-fold higher spectral changes and reflectivity change at the spectral dip of 14%. 
Therefore, under the usage of both polymers, the detection limit was improved and the author could 
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monitor the FIX at 100 fM with a reflectivity change of 6% (Figures 2.7d & 2.11). This result with the 
addition of N6-PEG represents a 1000-fold improvement in sensitivity.   
 
Figure 2.11.  FIX titration with different concentrations against constant aptamer (100 nM). FIX titers 
were shown with higher concentration to lower concentration.  Concentrations of other biomolecules 
are constant.  Black and red spectrums indicate only buffer and attachment of streptavidin conjugated 
GNP, respectively. SA-GNP used with 0.5 mg/mL of N6-PEG. Arrows indicate the direction of changes 
in the spectrum.  
 
In earlier reports, with the same aptamer and FIX interactions, the Kd values were found to be 600 
and 400 pM by using a filter binding assay and a commercially established SPR-based Biocore 
technique, respectively.  In both assays, the usage of proteins were nanomolar orders and statistical 
calculations were performed to calculate the Kd values.28,29  In the routine clotting assay it was found 
that in the presence of FIX-aptamer at low nanomolar order, clotting was delayed.29 
 
2.4.4. Biotin–streptavidin competition revealed the sensitivity enhancement 
To explore the reason behind the sensitivity improvement in the presence of N6-PEG, and to 
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determine the genuine interactions between biotinylated aptamer and SA-GNPs, the author studied 
dose-dependent biotin competition on the sensor surface (Figure 2.12a &b) ， viz., different 
concentrations of free biotin were mixed with SA-GNPs prior to application to the sensing chip.  
 
Figure 2.12. Competition assays using biotin. Different concentrations of biotin were added to SA-
GNP before reacting with pre-immobilized biotinylated aptamers on the sensing surface. (a) Schematic 
illustrates the experimental procedure. (b) Graphic representation of changes in the reflectivity, under 
competition. 
 
At low concentrations (0.1 fM of biotin), the presence of free biotin did not affect the result. However, it 
was interesting to note that with an increase in the biotin concentration there was a significant change 
in the spectral signal. These changes continued until a free biotin concentration reached 5 fM. At 
concentrations beyond 5 fM, there was a decline in the spectral changes of the waveguide sensor 
(Figure 2.13).  The maximum sensitivity was seen at a free biotin concentration of around 1.5–2.5 fM, 
as shown in Figure 2.12b. This implies that the binding affinity of SA-GNPs with respect to the surface 
biotin increases with increasing free biotin concentration up to 1.2 fM, suggesting that the competitive 
biotin molecules at a concentration of less than 1.2 fM might occupy some of the SA-GNP active 
binding sites. Although streptavidin has 4 active binding sites for biotin, several sites were occupied by 
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the free biotin under the above competitive situation, which might increase the affinity. This kind of 
competition has been reported recently by Duan et al.31 who studied the dissociation of streptavidin–
biotin complexes by addition of biotin in dose-dependent manner. A similar effect might be observed in 
the case of N6-PEG, viz., it could mask some of the biotin-active binding sites on the streptavidin. The 
results of the free biotin and SA-GNPs competition assays are illustrated in figure 2.12b. The crowding 
property of PEG might allow more SA-GNPs to properly align with the pre-immobilized biotinylated 
aptamers on the sensing plate. 
 
Figure 2.13. Spectrum of competition assays using biotin. Different concentrations of biotin were 
added to SA-GNP before reacting with pre-immobilized biotinylated aptamers on the sensing surface. 
Spectral changes after applying the mixture to biotinylated aptamer-immobilized sensing surface. 
Black and red curves are the spectra before and after the attachment of SA-GNP, respectively. The 
concentrations indicated in the figures are those of the biotin. Arrows indicate the direction of changes 
in the spectra. 
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2.4.5. Nanoscale imaging of captured GNPs on the sensing plate 
To substantiate the above results demonstrating a 1000-fold improvement in sensitivity with N6-
PEG, scanning electron microscope (SEM) analysis of the sensor chip surface was carried out. GNPs 
were clearly observed on the sensing plate used in the above experiments (experiments with single 
and double polymers) after attaching SA-GNP. Measurements were taken at different places and the 
number of attached GNPs was counted. The observations of the number of GNPs attached strongly 
corroborate the results obtained experimentally by the waveguide-mode sensor, viz., the number of 
GNPs from the sensing plate treated with only PEG-b-PAAc was about three times lower than from 
that treated with dual polymers (Figure 2.14a & b). 
 
Figure 2.14. SEM images of the surfaces of the sensing plates. FIX and the biotinylated aptamer were 
immobilized and PEG-b-PAAc was attached as a blocking material. (a) SA-GNPs were attached on 
them. (b) N6-PEG-coated SA-GNPs were attached on them. 
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2.4.6. Selective binding of aptamer to FIX in the presence of other proteins 
The author have confirmed above the high sensitivity of the present sensing system to FIX. To 
provide further information on the selectivity of the present system, sensing experiments were carried 
out in the presence of other proteins. The human blood clotting cascade involves clotting factors other 
than FIX, as well as major additional components such as albumin. Therefore, the author studied the 
reaction with the complex mixture of FIX containing FXIa and FVIIa, or albumin. FXIa is involved in the 
cleavage of FIX in the intrinsic clotting pathway, and FVIIa plays an important role in the cleavage of 
FIX during the extrinsic clotting pathway.29 These components of human plasma are present in 
different quantities: FIX, 3–5 µg/mL;32 FVIIa, 3.6 ng/mL;33 FXI, 3–6 µg/mL;34 and albumin, 45 mg/mL.35
If it can detect FIX selectively among these activation factors, it is anticipated that we will be able to 
precisely determine blood activation level. Albumin is one of the major components of blood protein 
(45 mg/mL; 50–70% of blood protein). It is therefore important to confirm that FIX can be detected in 
such a large excess of albumin. In the mixture containing human clotting proteins (FIX, FXIa, and 
FVIIa), at levels similar to those in human blood, the author could find the specific interaction of anti-
FIX aptamer with dose-dependent FIX (Figure 2.15).  Titrations were performed with concentrations 
lower than the saturation levels (5 pg/mL-55 ng/mL) from the above experiments using PEG-b-PAAc 
and N6-PEG.  We observed a similar detection limit (5 pg/mL) to that shown in the above experiments 
with a pure sample containing only FIX (Figure 2.16). This clearly indicates that the other clotting 
factors do not interfere with the detection of FIX using the EFC-WM sensor. The detection experiments 
were also carried out in the presence of albumin. As stated above, the concentration of albumin is 
quite high (670 µM; 45 mg/mL) compared to FIX (~3–5 µg/mL) in human blood; a ratio of ~8400:1. 
Considering the diluted blood sample, we used 5.6 mg/mL of albumin and 0.5 ng/mL of FIX, which 
represents the same ratio (8400:1). In the presence of 5.6 mg/mL of albumin, FIX detection to be 
suitable for normal blood sample analyses was carried out by the present waveguide-mode sensor 
system.
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Figure 2.15. Selective binding of aptamer with FIX in the presence of other proteins. The mixture of 
FIX, FXIa, FVIIa.  Kept FXIa (6 µg/mL) and FVIIa (8.4 ng/mL) concentrations as constant and titrated 
with different concentrations of FIX.  Black and red spectrums indicate only buffer and attachment of 
streptavidin conjugated GNP, respectively.  Arrows indicate the direction of changes in the spectrum. 
 
 
Figure 2.16. Selective binding of aptamer with FIX in the presence of FXIa and FVIIa or albumin. 
Titrations of different FIX concentrations against constant aptamer and other components are shown 
by graphical representation. FIX concentrations lower than saturation levels of previous experiments 
were used. 
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As can be seen in figure 2.16, 0.5 ng/mL of FIX in 5.6 mg/mL of albumin can be detected. In addition, 
the detection signal was clearly observed up to a level of 5 pg/mL (see Figure 2.17), which is 2 orders 
of magnitude lower than that of the normal level of FIX in blood.  
 
Figure 2.17. Spectra of selective binding of aptamer with FIX from the mixture of FIX and albumin. 
Albumin concentration was kept as 84 nM and titrated against different concentrations of FIX. Black 
and red spectrums indicate only buffer and attachment of streptavidin conjugated GNP, respectively. 
Arrows indicate the direction of changes in the spectrum. 
 
It is also confirmed that the detection limit is the same as that without albumin, as shown in figure 2.16. 
At present, an aptamer generated against FIXa is undergoing phase 2 clinical trials. Owing to its high 
specificity against FIXa in blood samples, this aptamer is injected into patients via percutaneous 
coronary intervention.36 FIX-aptamer also shown to work well with human plasma containing FIX and 
FIX-deficient plasma spiked with FIXa,29 both studies corroborates our results for the FIX in mixed 
protein samples. The detection system demonstrated in the present investigation, which is resistant to 
biofouling, would be useful in determining the abundance of FIX in blood samples containing multiple 
proteins. 
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2.5. Conclusions 
The author has designed a new biosensing system for detecting human coagulation FIX by 
using its aptamer and GNPs and a waveguide sensor. The Glu-modified sensor chip surface was 
brought into contact with the FIX sample, and was subsequently blocked using PEG-b-PAAc. This 
blocking treatment completely prevents non-specific binding on the sensor surface. It is interesting to 
note that coating of SA-GNPs by N6-PEG improved the detection limit to 0.1 pM. The higher sensitivity 
arises from the crowding effect of N6-PEG on the SA-GNPs, which occupy a certain number of the 
active biotin-binding sites on the streptavidin. Based on these results, it is concluded that PEG-b-PAAc 
and N6-PEG may be the ideal blocking agents for use in the development of an aptamer-based 
sensing system (aptasensor) with higher specificity. An FIX detection limit of 0.1 pM was attained even 
in the presence of other coagulation factors or a realistic albumin concentration. The strategy 
developed in this study by using an anti-FIX aptamer to detect minute amounts of FIX in a mixed 
sample (which represents blood serum) is highly recommended for finding clotting deficiencies in 
human samples. 
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3.1. Abstract 
Reporting clinically relevant biomolecular interactions is mandatory in the field of medical 
diagnosis. The major prerequisite of sensors includes measuring the specific target in a sample 
containing mixture of compounds, without compromising the convenience and sensitivity.  On the other 
hand, development of surface functionalization chemistries having higher non-fouling is important. In 
this stream-line, using Surface Plasmon Resonance (SPR) coupled with the blocking polymers, 
poly(ethylene glycol)-b-poly[2-(N,N-dimethylamino)ethyl methacrylate] (PEG-b-PAMA), and 
pentaethylenehexamine-terminated poly(ethylene glycol) (N6-PEG) a detection strategy was 
generated for the interaction of aptamer and human coagulating factor IX protein (FIX) because its 
presence is extremely low in vivo and important. Initially gold (Au) sensor chip of SPR was modified 
with PEG-b-PAMA followed by SH-dT20 and duplexed with anti-factor aptamer extended with A24. 
Further, N6-PEG was co-immobilized on sensing surface to quench the bio-fouling completely. On this 
dual tethered PEGylated-surface, the author determined the dissociation constant as 37±10 pM for 
FIX and aptamer interaction and could reach the sensitivity to 800 fM with aptamer-FIX-antibody 
sandwich pattern detected by GNP-conjugated anti-mouse antibody. The author could detect FIX with 
the abundance of albumin. Further, to mimic real detection of FIX in the clinical sample, the author 
demonstrated the experiments evidence with human plasma instead of FIX. Higher-sensitivity was 
attained due to dual polymers immobilized on Au surface and it can be a common strategy for any 
aptamer-protein interactions.  Selective binding of the aptamer in the human blood serum shown here, 
makes suitability of present strategy for detecting of clinically relevant samples. 
 
3.2. Introduction 
 Biomolecular recognition is considered as mandatory to convey the importance of 
biomolecules to understand the events of disease and gene regulations. First reported biosensor was 
in 1962 having signal recognition elements and transducers, as the basic for sensor development.1 
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After this initiation, various sensors have been proposed to report biomolecular interactions, operate 
with principles designed for surface plasmon.2 Among different sensing systems, Surface Plasmon 
Resonance (SPR) and other sensors mimics SPR dominates as a major in label-free or labeled ways 
of detection.3  However, a way of detection without chemical tags is highly welcome for scalable 
biosensor technology with real-time monitoring with compromised sensitivity. Even though, the 
sensitivity varies with different systems, sensitivity is the prime determining factor for the quality of the 
succeeded sensors.4 Different surface functionalization chemistries with suitable probes have been 
proposed to improve the sensing system.  In a very early stage of sensor development, antibody was 
used as the probe and in 1967 first immobilized antibody solid surface was proposed by Catt and 
Niall5 and later an advanced methods such as Enzyme linked Immunosorbent Assay (ELISA) was 
introduced followed by several antibody sensing strategies on solid surfaces were established.6,7  
Even though antibodies are potential molecule for the sensor developments in the past several 
decades, in 1990 an alternate molecules to substitute the antibodies was developed called `aptamer` 
or ‘chemical antibody’.  A strategy called Systemic Evolution of Ligands by Exponential Enrichment 
(SELEX) was introduced to generate the aptamers by three independent researchers, to find the 
selective molecules from the randomized molecules.8-10 Aptamers are having the potential 
characteristics and behave equal to the antibodies.  Combination of antibody and aptamer sensing 
strategy have been proposed as these molecules could complement each other.11 
 
 Aptamers or antibodies immobilized solid surfaces have a lower antigen capturing efficiency 
compared with the condition under solution due to random orientations and steric hindrances by 
interaction with the solid surface.12-14  To fabricate an efficient solid-surface sensor, the proper 
immobilization of probe or receptor molecule on the surface of sensor is a crucial step and correctly 
oriented higher density immobilization would leads an improved  level of detections.14  Right 
orientation of biomolecules on the solid surface was succeed with the strategies of co-immobilization 
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of inert materials such as polymers.15  Poly(ethylene glycol) (PEG) is one of the popular polymers, 
shown to have non-fouling due to their flexible nature,  play an important role in the fields of biology.16-
21 PEG-b-polymers modified surfaces are highly efficient in reducing protein adsorption from mixture of 
sample, such as blood thereby improving the biocompatibility.22,23  
 
 
Figure 3.1. Setup in Surface Plasmon Resonance.  (a) Principle in SPR for ligand and analyte 
interaction.  The sensing surface (Au) used in SPR-Biacore is shown.  (b) Typical angular changes in 
SPR, upon the complex formation of ligand and analyte. (c) Association and dissociation process in 
SPR for ligand and analyte interactions. 
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Natural polymers such as Bovine Serum Albumin (BSA) and Casein may not help in these aspects as 
it contains IgG that may cause an obstacle to antigen and cross-react with secondary antibodies.24  
PEG-based polymers have driven to overcome this issue, can synthesize chemically with varied 
lengths to generate high performance sensors.15,25-28 Densely packed PEG tethered-chain surfaces, 
having the combination of long and short PEG dual chains greatly reduces non-specific adsorption 
onto the sensing surface.19,29-32  
 
On the other hand, among different reported solid sensing surfaces, gold (Au) is one of the 
preferred metals for the sensing due to easy water dispersal, compatibility with surface 
functionalization, biological non-reactivity, and ability to be tailored with uniform and different nano-
sizes.33-37 In this report, a combination of Au surface and PEG-polymers were used to develop the 
higher sensing system with the assistance of a SPR-based Biacore system.  SPR is known as the 
excitation of surface plasmon by monochromatic waves on the metal coated surface surrounded by 
biological fluid environment and the excitation of surface plasmon by light is denoted as a SPR.  
Absorption of molecule on the receptor layer of biosensor changes the refractive index of the layer, 
reporting the event of binding (Figure 3.1a-c). Using a SPR, the strategy with sandwich pattern of 
aptamer- FIX-antibody was performed to demonstrate the applications of PEG-b-polymers, namely, 
PEG-b-poly[2-(N,N-dimethylamino)ethyl methacrylate] (PEG-b-PAMA) and pentaethylenehexamine-
terminated PEG (N6-PEG). 
 
The biological importance of FIX was demonstrated in Hemophilia B (Christmas disease), 
when the FIX concentration in plasma gets abnormal from the normal level which is around 5 μg/mL 
(87 nM). The human plasma has clotting factors other than FIX, as well as major additional 
components such as albumin (45 mg/mL). It is therefore important to confirm that FIX can be detected 
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in such a large excess of albumin. If we can detect FIX selectively among additional components, it is 
anticipated that we will be able to precisely determine the active level of FIX.  In this study, the author 
demonstrated the detection of FIX with sensing strategy as follows: (i) initially Au sensor chip of SPR 
modified with PEG-b-PAMA followed by SH-dT20; (ii) complementation of aptamer-A24 with SH-dT20 (iii) 
unreacted Au surface was blocked by N6-PEG (iv) FIX was allowed to interact with aptamer (v) anti-
FIX mouse IgG passed on the FIX modified surface (vi) anti-mouse IgG antibody conjugated-gold 
nanoparticle (GNP) was allowed to interact with anti-FIX antibody (vii) interaction was measured by 
SPR. 
 
3.3. Experimental section 
3.3.1. Reagents and biomolecules 
Anti-mouse IgG (H+L) - 40nm GNP Conjugate from Cytodiagnostics, All oligos are 
commercially synthesized from Tsukuba Oligo company. TaKaRa Ex Taq, DuraScribe® T7 
Transcription Kit, 3-mercaptopropionic acid, Factor IX, Monoclonal Anti-Factor IX antibody produced in 
mouse, Human serum and BSA from Sigma Aldrich, St. Louis, USA. Sensor chip from GE healthcare, 
Tokyo, Japan.  N6-PEG was kindly provided by JSR (Tokyo, Japan).  Synthesis of PEG-b-PAMA is 
outlined by Miyamoto et al. and Horiguchi et al.38,39  All reagents were stored according to the 
suppliers’ recommendations. 
 
3.3.2. Western blot analysis   
The specificity of the antibody for the FIX was analyzed by standard blotting assays with an 
appropriate antibody. In brief, for western blot analyses, FIX was separated by sodium dodecyl sulfate 
(SDS)-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride (PVDF) 
membrane.  After immobilization of the protein, the membrane was blocked with 3% nonfat milk in 
Tris-buffered saline (TBS) at room temperature for 1 h and then treated with a 1:10,000 dilution of the 
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primary antibody (anti-FIX) at 4°C overnight.  After removal of unbound primary antibody by washing, 
the membrane was incubated for 1 h with horseradish peroxidase (HRP)-conjugated goat anti-mouse 
immunoglobulin G (secondary antibody).  The immunocomplexes thus formed were visualized by 
staining with ECL-plus western blotting detection solution.  The specificity of primary antibody 
interactions with secondary antibody was analyzed by a standard dot-blotting method using different 
dilutions of primary antibody, and immunocomplexes were identified using a 1:1000 dilution of 
secondary antibody, followed by ECL-plus western blotting detection. 
 
3.3.3. Enzymatic synthesis of aptamer  
A stable 33-mer (2′-fluoro-modified) RNA-aptamer (FIX-aptamer), which was previously reported 
by Rusconi et al.40 was prepared and its ability to bind FIX or FIXa was verified.40,41 Detailed the 
preparation of FIX aptamer by in vitro transcription is in chapter 2.  
 
3.3.4. Interactive analyses of aptamer and FIX 
 Initially Au sensing surface of SPR was modified with PEG-b-PAMA followed by SH-dT20 and 
duplexed with FIX-aptamer extended with A24. Different concentrations of FIX (0.8 pM to 80 nM) were 
injected to determine the dissociation constant and the limit of detection. On the FIX immobilized 
surface anti-FIX mouse antibody (FIX-antibody) followed by GNP-conjugated anti-mouse IgG (mouse 
IgG-GNP) was passed. A four line Biacore system (Biacore 3000) used for all the experiments. Among 
these, one flow channel was always used for control experiment. Flow rates carried out are as follows, 
PEG-b-PAMA (10 µL/min, 300 µl), SH-dT20, Aptamer-A24  (2 µL/min, 20 µL), N6-PEG (10 µL/min, 300 
µL),  FIX, FIX antibody, mouse IgG-GNP (10 µL/min, 50 µL). Immobilized aptamer was regenerated by 
10 mM NaOH (60 µL/min,5 µL). All the measurements were carried out at 25º C. To find the saturated 
concentration of each biomolecule for the strategy above explained, the 
author titrated the optimal biomolecule concentration. For that, first different concentrations of PEG-b-
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PAMA (2 mg/mL to 50 mg/mL) were injected on the Au surfaces. Then different concentrations (1 µM 
to 5 µM) of SH-dT20 were injected on the optimized PEG-b-PAMA immobilized surfaces. Similarly, we 
also titrated the aptamer concentrations from 500 nM to 1000 nM on the optimized SH-dT20 modified 
surfaces. FIX-antibody titration (25 nM to 200 nM) was also carried out on the FIX (200 nM) 
immobilized surfaces.  
 
3.3.5. Interactive analyses of antibody and FIX  
 The Au surface modified with COOH, using 3-mercaptopropionic acid to immobilize the FIX 
antibody. Before that initially the author did pH scouting on surface modified with COOH to immobilize 
the FIX antibody. 2 nM of FIX-antibody diluted individually with different pH (4, 4.5, 5.0, and 5.5) and 
passed directly on the COOH modified surfaces. With the suitable pH, the antibody was immobilized 
on the COOH modified Au surfaces after activated by 100 mM N-hydroxysuccinimide (NHS) and N-
ethtyl-N’-(3-dimethylaminopropyl)carbodiimde hydrochloride (EDC). Then, remaining free COOH-
surfaces were blocked by 10 mg/mL of N6-PEG or 1 M ethanolamine.  Different concentrations of FIX 
(30 nM to 240 nM) were injected on the FIX-antibody immobilized surfaces. For the comparison of our 
surface modification the same experiment was done with the commercial CM5 chip. 
 
3.3.6. Dissociation constant of FIX-aptamer and FIX-antibody against FIX 
 To find the dissociation (Kd) value of FIX and aptamer, different concentration of FIX (15 nM to 
120 nM ) on the constant (500 nM) aptamer injected immobilized surfaces. And also to check the FIX-
antibody dissociation constant, the author injected different concentrations of FIX (30 nM to 240 nM) 
on the constant FIX-antibody (200 nM) immobilized surfaces. Kd value is calculated using the BIA-
Evaluation software by association and dissociation of FIX on aptamer and antibody immobilized 
surfaces. The rate of association was measured from the forward reaction, and the dissociation rate 
was measured from the reverse reaction. The equilibrium dissociation rate constant (Kd) was 
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calculated by kd/ka, (Kd- equilibrium dissociation constant; kd - dissociation rate; ka - association rate). 
 
3.3.7. Sandwich assay  
To detect the FIX here the author performed two kinds of sandwich assay, such as aptamer-FIX-
antibody (200 nM antibody was passed on the aptamer-FIX immobilized surfaces) and antibody-FIX-
aptamer (500 nM aptamer was passed on the antibody-FIX immobilized surfaces). Different binding 
sites of aptamer and antibody on FIX was confirmed by SPR and gel-shift assay. For SPR, on the 
aptamer and FIX (120 nM) immobilized surface, different concentrations (25 to 200 nM) of antibody 
were passed (10 µL/min, 50 µL). For the gel-shift assay, the author used the native polyacrylamide gel 
electrophoresis (Native-PAGE). Before loading on the gel, aptamer (0.3 µg) was denatured at at 90ºC 
for 2 min and cooled to room temperature then pre-mix was made with different ratios of FIX (1:3, 1:6 
and 1:9) in 10 mM Hepes-KOH (pH 7.4) buffer containing, 150 mM NaCl and 2 mM CaCl2.  CaCl2  was 
added after the denaturing step. Similarly, aptamer:FIX:antibody pre-mix was made with different 
ratios (1:3:6, 1:3:12, and 1:3:24).  After incubation at room temperature for 10 min, all mixes were 
resolved on 10% Native-PAGE.  Control lane was loaded with only the denatured aptamer.  Gel was 
run with 150 V for 1 hr and stained with ethidium bromide.  After that gel was detained with ddH2O and 
image was photographed.  
 
3.3.8. Limit of detection of FIX in the presence of albumin or human plasma  
To check the limit of detection of FIX the author titrated with the FIX concentrations from 0.8 
pM to 80 nM on the FIX-aptamer (500 nM) immobilized surfaces followed by the constant FIX-antibody 
(200 nM), and mouse IgG-GNP (0.1 OD). Control experiments were carried out with complementary of 
FIX- aptamer. Limit of detection is calculated with the value 3 times higher resonance changes than 
the control experiment.. For selective binding which mimics a similar situation in the blood samples, 
experiments with mixed albumin was carried out.  Different concentrations of FIX (from 0.8 pM to 8000 
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pM),mixed with constant higher concentration of albumin (45 mg/mL) passed on the FIX-aptamer 
immobilized surface.  Then constant FIX-antibody (200 nM) and mouse IgG-GNP (0.1 OD) were 
injected. To detect the FIX in the human plasma, instead of FIX, the author injected different diluted 
human plasma from 1:10 to 1:1280, with half serial dilutions. All other surface chemical modifications 
and detection strategies were the same as those described above.  
 
3.4. Results and Discussion 
3.4.1. PEG-b-PAMA assisted immobilization of Aptamer on Au surface 
Prior to check the interaction of aptamer and FIX, preliminary assessment was performed by 
immobilizing PEG-b-PAMA on Au surface at different pH of acidic (4.0), neutral (7.4) and alkali (9.0). 
The responses obtained by SPR were similar with all the above pH conditions, indicates the stability of 
PEG-b-PAMA under these conditions.  Similar uneffectiveness of varied pH conditions was reported by 
Yoshimoto et al.42 It was reported that adsorption of PEG-b-PAMA on the Au surface was not affected 
by strong ionic condition.42,43  Due to ideal condition with the SPR system recommended by 
manufacturer, neutral condition (pH 7.4) was desired for further experiments.  At this pH the response 
was reached (1200 RU) with 6 mg/mL of PEG-b-PAMA reconstructed surface and the response will 
increase further to only a few hundreds upon increasing the concentration to 12, 25, and 50 mg/mL. 
The saturation level was attained at PEG-b-PAMA concentration of 6 mg/mL. PEG-b-PAMA 
attachment on Au was occurred through the reaction of the lone pair of the amino groups of the PAMA 
chain, having a strong affinity to the Au atoms.39 The polyamine segment PEG-b-PAMA interacts with 
a Au surface via co-ordination of nitrogen atom.43 After attach the PEG-b-PAMA, the author analysed 
the immobilization of thiolated-DNA oligo (SH-dT20) on the PEG-b-PAMA modified Au surface, in order 
to make the duplex with the aptamer to be analyzed (Figure 3.2a).  Clear response (600 RU) was 
observed with 1 µM level.  The response was increased further when the concentration of SH-dT20 
was increased to 2 µM (900), at the concentration of 3 µM (980) higher immobilization of SH-dT20 on 
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PEG-b-PAMA surface was attached with the saturation level.  Whereas, when the PEG-b-PAMA was
neglected from the sensing surface, lesser SH-dT20 was bound even at this concentration (Figure 
3.2b).  Inclusion of PEG-b-PAMA saturated with 3 µM of SH-dT20 and promotes the proper attachment 
due to the cationic charge of the PAMA segment on the periphery of the Au surface.39  
 
Previously, it was reported that PEG-b-PAMA co-immobilized surface with SH-ssDNA supports 
the proper duplex formation and behave efficiently.44-46  Yoshimoto et al.45 have found the role of PEG-
b-PAMA on Au surface for the immobilization of SH-DNA and it would be stronger even under stringent 
aqueous condition.  Sulfanyl-group with single strand DNA has strong interaction on Au surface was 
reported to be potential when co-immobilized with PEG and the increment until 5 folds compared to 
the baregold.45 
 
 
Figure 3.2. Evaluation of immobilization of SH-dT20 and aptamer-A24 duplex formation on Au surface.  
(a) Schematic for SH-dT20 and aptamer-A24 duplex. (b) analyses of SH-dT20 and aptamer-A24 in the 
presence and absence of PEG-b-PAMA. Tested with 3 µM of SH-dT20 and 500 nM of aptamer-A24.  
Cartoon as inset illustrates the strategies. 
 
With this ideal situation, a stable FIX-aptamer (2’ fluoro-modified) extended with A24 (20 
bases for complementation and 4 bases for spacer), was passed.  With the injection of FIX- 
aptamer, the author could notice the proper duplex of aptamer on the SH-dT20 with nicely displayed 
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sensogram to 900 RU, with the concentration of 500 nM. The aptamer-A24 interaction with the SH-dT20 
noticed with higher response on the PEG-b-PAMA modified surfaces compared to the surface free 
from PEG-b-PAMA (Figure 3.2b). The optimal PEG chain density on the surface might improve the 
orientation of the immobilized SH-dT20 resulting in an improvement in the aptamer immobilization. A 
suitable density of surrounding PEG chains prevented the immobolized aptamer from lying down or 
nonspecically bind on the Au surface, and improve the conjucation efficacy with the FIX. This 
concentration (500 nM) against the saturated level of SH-dT20 with 3 µM is in the ratio of 6:1 (aptamer: 
SH-dT20). The responses of sensogram at these two concentrations are same even the ratio are 
different, this might be due to difference in the size of these two molecules. 
 
3.4.2. Co-immobilization of PEG-b-PAMA and N6-PEG promotes non-biofouling on Au surface 
for detection of FIX  
After aptamer immobilization the remaining Au surface was masked by BSA with higher 
concentration (45 mg/mL).  On this BSA masked surface the author injected by different 
concentrations of FIX in the HEPES buffer containing calcium ions.   
 
Figure 3.3.  Determination of stability of aptamer upon N6-PEG attachment. Immobilization of FIX on 
the Aptamer-N6-PEG modified surface (Red) and N6-PEG-aptamer modified surfaces (blue). 
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Inclusion of calcium ions to the reaction mix mimics the physiological conditions under which blood is 
enriched with calcium.  In the absence of calcium ion aptamer could not interact with FIX 40,47.  Even 
though, with the assistance of BSA, the author could observe the specific interaction of aptamer and 
FIX, there was non-specificity still exists. Efficiency of BSA blocking is might be less, due to acidic 
nature of BSA.48   Further, BSA blocked surface has negative charge and compete with the 
interactions of negatively charged protein to be analysed and also mask the preloaded antibody from 
the complex formation.48  To overcome this issue, the author used N6-PEG blocking instead of BSA 
after aptamer immobilization. N6-PEG (6 kDa) has 6 amino groups at one end of the chain to interact 
with Au surface. N6-PEG has eletrostatically attractive force and this effect is three times higher than 
PEG with mono-amine end.15 The coordination of the lone pair of the amino groups to the Au surface 
is involved in this reaction makes Au-surface is long-term stable than a common Au-S linkage.15,30,49,50   
  
 
Figure 3.4.  Determination of dissociation constant. (a) FIX-aptamer interaction. FIX with different 
concentrations (7.5 to 120 nM) were passed on the FIX aptamer immobilized surface. (b)  FIX-
antibody interaction. FIX with different concentrations (15 to 240 nM) were passed on the FIX antibody 
immobilized surface. Samples were injected at the flow rate of 10 µl/min. All experiments were 
performed with 10 mM HEPES buffer (pH 7.4) containing 150 mM NaCl and 2 mM CaCl2. Figure inset 
is shown for purity of FIX on SDS-PAGE and FIX-antibody specificity by western blot analysis. 
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To determine the strength of the attached N6-PEG the author tested with two kinds of experiments, in 
one set-up after attach aptamer, N6-PEG was passed and in other case, it is vise-versa (passed N6-
PEG then aptamer).  In both cases, the author could find the same kind of responses, even with the 
consequent injections of FIX with different concentrations (Figure 3.3). These increments with N6-PEG 
indicate the specificity occurred with the assistance of PEG-b-PAMA and N6-PEG for aptamer and FIX 
interactions.  Previously, higher increment in the S/N with N6-PEG was reported compared with BSA 
as the blocking agent.30  Moreover, the isoelectric point (pI) of BSA (4.7) is lower than the experimental 
condition performed (pH 7.4), as stated by Nagasaki.15 
 
3.4.3. Dual polymers-assisted interaction - Determination of dissociation constant of aptamer 
and FIX 
 
 To access the dissociation constant of FIX and FIX-aptamer interaction in the presence of 
PEG-b-polymers, the author performed the experiments with different combinations of PEG-b-
polymers and compared BSA blocked Au surface.  These combinations include, only BSA, only N6-
PEG, only PEG-b-PAMA, PEG-b-PAMA with BSA and PEG-b-PAMA with N6-PEG.  Based on the 
responses of lower concentrations  (15 to 120 nM) of FIX obtained, (Figure 3.4a) evaluation was done 
using the Biacore Evaluation software, and were fitted with a 1:1 binding model (for the interaction 
between aptamer and FIX according to the equation A+B=AB). The lowest dissociation constant (Kd) 
(highest sensitive) for aptamer and FIX interaction was 37±10 pM with the combinations of PEG-b-
PAMA and N6-PEG. However, in other cases for the same interaction, Kds were 684±15 pM (only 
BSA), 278±8 pM (only N6-PEG), 142±5 pM (only PEG-b-PAMA) and 80±7 pM (PEG-b-PAMA and 
BSA) (Table 3.1).   Based on the comparison between these results, it seems the association rate is 
nearly same in all the cases, whereas there were changes in dissociation rates, indicate difference in 
the stability of the biomolecular attachment in the presence PEG-b-polymers. 
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Table 3.1. Kinetic parameters for the interaction of aptamer and FIX in the presence of different 
combinations of PEG-b-polymers 
 
Among these choices, a dual PEG-polymer (PEG-b-PAMA with N6-PEG) has shown higher responses, 
makes the clear appealing application of PEG-b-PAMA, which made the proper construction on the 
sensing surface. On the other hand N6-PEG improved the non-fouling and completely controlled the 
bio-fouling.  Previously, it was proved that the KD of FIX and aptamer is 580 pM by filter binding 
assay.40  In this study, PEG-b-PAMA with N6-PEG polymers are drastically reduce the back-ground 
noice and improve the sensitivity and specificity.  Higher molecular weight blocking agents [BSA (66 
kDa), casein (>20 kDa) and gelatin (>100 kDa)] causes interference with molecular recognition site, 
whereas polymers are having lower molecular weights (~10 kDa).15  
 
3.4.4. Determination of dissociation constant of antibody and FIX on the N6-PEG modified 
COOH surface 
 
To compare the interactions of aptamer and FIX, the author also evaluated the Kd of FIX-
aptamer, FIX-antibody interaction on COOH modified Au surface and the commercially availed CM5 
chip.  The author could observe the specific binding of FIX to the antibody on the Au surface in dose-
dependent manner with N6-PEG or ethanolamine as a blocking (Figure 3.4b). It was also noticed the 
binding of FIX even in the absence of antibody when ethanolamine used as a blocking. (Figure 3.5a). 
Ethanolamine is considered as one of the believable blocking for the COOH modified surfaces, but still 
some of the active group on the COOH surface gives non-specificity with FIX, because amine in the 
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protein easily bind on the COOH surface. To avoid these nonspecific bindings one way is to block the 
remaining COOH on the surfaces. Here, the author used N6-PEG instead of ethanolamine and it was 
found that complete quenching of nonspecific binding of FIX by the strong interaction of amine groups 
in the N6-PEG with COOH surfaces and gradually increase the specific response with different 
concentrations of FIX on FIX-antibody (Figures 3.4b & 3.5b).  N6-PEG not only suppresses the bio-
fouling as shown in the figure and also increases the responses compared with ethanolamine blocked 
surface. The author found that N6-PEG is the suitable blocking agent for Au surface, and also its very 
effective on COOH modified surfaces. When different concentrations of FIX was injected on the FIX- 
antibody hybridized N6-PEG surfaces the author could see the clear increment with increasing 
concentration of FIX and the KD for specific interaction of FIX and antibody were determined as 48±12 
nM (Figure 3.4b).  It is interesting to note that in both aptamer-FIX and antibody-FIX interactions, N6-
PEG played a major role to prevent the bio-fouling.  For comparision the author also did the same 
antibody-FIX using the commercially COOH modified CM5 chip. It was found that the same response 
increases with FIX and anti-FIX antibody interaction on both N6-PEG and ethanolamine blocked 
surfaces (Figure 3.6 a,b). 
 
Figure 3.5.  Comparative analyses between ethanolamine and N6-PEG for FIX-antibody and FIX 
interaction. SPR analyses for the specific and non-specific interaction in the presence of (a) 
ethanolamine and (b) N6-PEG.  
 
The kD was found as 25±15 nM, which is very close to N6-PEG modified surface (Table 3.2). However, 
it can be inferred that N6-PEG modified surface is much cheaper than commercial available CM5 
surface. 
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Figure 3.6.  Comparative analyses on CM5 chip, between ethanolamine and N6-PEG for FIX-antibody 
and FIX interaction (a) SPR analyses in the presence of ethanolamine. (b) SPR analyses in the 
presence of N6-PEG. Cartoon illustrates the complex formation on the Au surface Samples were 
injected at the flow rate of 10 µL/min. All experiments were performed with 10 mM HEPES buffer (pH 
7.4) containing 150 mM NaCl and 2 mM CaCl2.  
 
 
Table 3.2. Kinetic parameters for the interaction of FIX-antibody and FIX in the presence of or N6-PEG.  
 
3.4.5. Aptamer-FIX-antibody sandwich on PEGylated Au surface 
Based on the above study with FIX interactions with two different probes (aptamer and antibody), 
the author designed the sandwich pattern on the aptamer-FIX immobilized surface by interacting with 
FIX- antibody.  In the past, aptamer-antigen-antibody sandwich assays have been considered to 
obtain a higher sensitive.11 When make the sandwich assay, the key issue is the availability of two 
different binding sites on the target protein (FIX) for different probes (aptamer and antibody).  To make 
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sure about this issue, the author carried out confirmations with two kinds of experiment by SPR and 
gel-mobility shift. When pass the antibody on the aptamer-FIX immobilized surface of SPR, the author
could see the concentration dependent attachment of anti-FIX antibody (Figure 3.7a).   
 
 
Figure 3.7.  Analyses of sandwich formation with aptamer-FIX-antibody.  (a) SPR analyses for the 
complex formation of aptamer-FIX-antibody on surface modified by PEG-polymers. After 
immobilization of aptamer (500 nM) and blocking with N6-PEG on Au surface FIX (200 nM) was 
attached. On the FIX immobilized surface different concentrations of anti-FIX antibody were passed. 
Figure inset is cartoon for this complex. Samples were injected at the flow rate of 10 µl/min. (b) Native-
PAGE for the complex of aptamer-FIX-antibody.  Shift and super-shifts were shown with aptamer-FIX 
and aptamer-FIX-antibody complexes.  All experiments were performed with 10 mM HEPES buffer (pH 
7.4) containing 150 mM NaCl and 2 mM CaCl2.  
 
This results confirm that the formation of sandwich pattern of aptamer-FIX-antibody on the sensing 
surface.  Similarly, it was also evaluated the sandwich formation on the electrophoresis analyses by 
resolving different complexes (only aptamer, aptamer-FIX and aptamer-FIX-antibody) on the native-
PAGE.  The resolved gel-pattern showed a clear shift with aptamer-FIX complex and super-shift with 
aptamer-FIX-antibody complexes in dose-dependent manner (Figure 3.7b). Previously, by applying 
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PEG/Antibody co-immobilized magnetic beads combined with a fluorescent system, a sandwich ELISA 
pattern was developed by our research team to detect alpha-fetoprotein.30 In several instances 
aptamers are proposed as equal or better molecule than antibodies, however, both aptamer and 
antibody can complement each other in sandwich assays.11  
 
 
Figure 3.8.  Analyses of two different sandwich patterns on PEGylated surface.  Aptamer-FIX-antibody 
and antibody-FIX-aptamer sandwiches were compared. On the aptamer or antibody modified surfaces 
FIX was injected (from 15 to 120 nM). Figure inset is cartoon for this complex. Samples were injected 
at the flow rate of 10 µL/min. 
 
The author also compared two different sandwich types, namely, aptamer-FIX-antibody and antibody-
FIX-aptamer on the dual polymer (PEG-b-PAMA and N6-PEG) immobilized Au surface. With FIX 
concentration of 120 nM, the response obtained was 350 RU in the case of aptamer-protein-antibody 
sandwich pattern. Whereas, under similar condition only the response of 50 RU was obtained by 
antibody-FIX-aptamer strategy, showing about 7 folds lesser efficiency with antibody-FIX-aptamer 
sandwich.   Similarly, with the injection of different FIX concentrations (15 to 120 nM), the aptamer-
FIX-antibody strategy has shown the better responses, indicates the higher affinity between aptamer 
and FIX are suitability of aptamer-FIX-antibody strategy (Figure 3.8). 
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3.4.6. Sensitive detection using mouse-IgG-GNP on PEG-b-PAMA and N6-PEG co-immobilized 
Au surface for detection of FIX in mixed sample 
 
Based on the above sandwich pattern, the author formulated a strategy with mouse IgG-GNP 
for higher sensitivity on the FIX antibody. Before check the sensitivity assisted with mouse IgG-GNP, 
the author evaluted the necessary amount of N6-PEG to block the Au surface and to reduce the non-
specificity of mouse IgG-GNP on the sensing surfaces. For that, the author did the control experiment 
with different concentration of N6-PEG from 0 to 5 mg/mL of N6-PEG on the sensing surface in the 
absence of FIX. On the N6-PEG immobilized surface, mouse IgG-GNP did not show
Non-specific binding, whereas in the absence of N6-PEG there was non-specificity. With increase in 
the N6-PEG concentration, the non-specificity decreased concomitantly, at the concentration with 
5mg/mL N6-PEG, complete abolish in the nonspecific binding was occurred (Figure 3.9).  
 
Figure 3.9.  Analyses of non-specific attachment of mouse-IgG-GNP on N6-PEG modified surface.  
Different concentrations (1, 2 and 5 mg/mL) of N6-PEG were tested. Samples were injected at the flow 
rate of 10 µL/min. 
 
This optimized concentration (5 mg/mL) of N6-PEG was used for further experiments with 
mouse IgG-GNP. The strategy to detect the FIX assisted with mouse IgG-GNP is shown in Figure 
3.10a.  With this strategy, the author performed the experiments on SPR with different combinations of 
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blocking agents (only BSA, only N6-PEG, only PEG-b-PAMA, PEG-b-PAMA with BSA and PEG-b-
PAMA with N6-PEG) and injected FIX. When the author injected 80 nM of FIX, a dual PEG-polymer 
(PEG-b-PAMA with N6-PEG) was shown to be with higher display of responses (Figure 3.10b).  The 
author could observe 3 fold higher responses in the presence PEG-b-PAMA and N6-PEG compared 
with BSA as a blocking.  Moreover, almost no non-specific attachment of mouse IgG-GNP was
noticed on this surface.  With this dual polymer surface construction, we determined the limit of 
detection of FIX as 800 fM with the response of about 200 RU. With increasing the
FIX concentration, the author could observe the clear increment in the responses (Figure 3.11).   
 
 
Figure 3.10. Detection of FIX by mouse-IgG-GNP. a) Schematic of chemical surface modifications on 
the Au surface of the SPR-sensing surface for aptamer and FIX interactions. (b) Determination of the 
binding of FIX for the interactions of aptamer on Au surface with different surface modifications. 80 nM 
of FIX was injected on the different surface modifications followed by FIX antibody and analyzed by 
mouse IgG-GNP. 
 
The biological importance of FIX was demonstrated in Hemophilia B (Christmas disease), 
when the FIX concentration in plasma gets abnormal from the normal level which is around 5 μg/mL 
(87 nM). This plasma sample containing albumin as the major protein with other clotting factors in 
addition to FIX. If one can detect FIX selectively among these activation major proteins, it is 
anticipated that the author will be able to precisely determine active level of FIX. Human blood serum 
containing albumin to the level of ~45 mg/mL (~55%) and glubulin to the level of ~25 mg/mL 
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(~38%).24,47  To check the selective binding of FIX in the presence of albumin, the author performed 
the experiment using FIX mixed with high concentration of albumin (45 mg/mL), and with this real 
albumin concentration in serum the author could detect FIX at 80 pM (Figure 3.11).  
 
Figure 3.11. Limit of detection of FIX in the presence or absence of albumin. FIX (from 0.008 to 
80,000 pM) only or mixed with 45 mg/mL of albumin passed on the FIX aptamer immobilized surfaces 
followed by FIX antibody and detected by mouse IgG-GNP. Samples were injected at the flow rate of 
10 µL/min. All experiments were performed with 10 mM HEPES buffer (pH 7.4) containing 150 mM 
NaCl and 2 mM CaCl2.  Detection limits are indicated by arrows. Figure inset shows the abundance of 
albumin in human plasma. 
 
The attained higher sensitivity with sandwich pattern detected by mouse IgG-GNP, was due to PEG-b-
PAMA and N6-PEG immobilized Au surface, can be used as the common strategy for any aptamer-FIX 
interactions. Further, SH-dT20 and aptamer-A24 duplex could be regenerated by injecting 10 mM NaOH, 
on the sensing surface (Figure 3.12).  The author detected FIX with the abundance of albumin which 
mimics physiological condition makes suitability of present strategy for detecting FIX deficiency in 
human blood samples.   
 
Figure 3.12.  Regeneration on the sensing surface. (a) cartoon illustrates the regeneration process. 
(b) Regeneration by SPR. Regeneration was performed by 10 mM NaOH, injected at the flow rate of 
60 µl/min, for 2 x 5 sec. Performed with 10 mM HEPES buffer (pH 7.4) containing 150 mM NaCl. 
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3.4.7. Detection of FIX in human plasma on co-immobilized PEG-b-PAMA and N6-PEG modified 
Au surface 
 
Human blood serum also containing other clotting factors including FIX involved in the human 
clotting system and participates in the cleavage in the intrinsic and the extrinsic clotting pathways41, in 
addition to albumin and globulin.  To confirm the above results with further step, the author directly 
used human plasma and evaluated the existing FIX using the designed strategy with mouse IgG-GNP.  
The author evaluated the serially diluted human plasma from 1:10 to 1:1280 which are equivalent to 
the dilutions from 8 nM to 0.062 nM of FIX.  Upon injection, the author could observe the clear 
changes in the sensogram from the diltution of 1:160 which is equivalent to 500 pM of FIX With this 
concentration the changes in the sensorgram was 250 RU (Figure 3.13 a,b).  
   
 
Figure 3.13. Detection limit of FIX in human plasma. (a) SPR analysis. Human plasma with dilution 
from 10 to 1280 injected on the FIX aptamer immobilized surfaces (Instead of FIX protein) followed by 
FIX antibody and analyzed by mouse-IgG-GNP. (b) Graphical representation of analyses of aptamer 
against different dilutions of human plasma containing FIX by SPR. The real concentrations are 
indicated. Samples were injected at the flow rate of 10 µl/min. All experiments were performed with 10 
mM HEPES buffer (pH 7.4) containing 150 mM NaCl and 2 mM CaCl2.  Samples were injected at the 
flow rate of 10 µL/min. 
 
Specific interactions of aptamer and FIX were further evaluated using complementary aptamer 
sequence and no binding was noticed both by gel-shift assay and SPR analyses (Figure 3.14).  
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Figure 3.14.  Analyses of FIX in human plasma.  Human plasma with dilution 1:10 was injected on the 
FIX aptamer immobilized surfaces (Instead of FIX protein) followed by FIX antibody and detected by 
mouse –IgG GNP. Control experiment was done with complementary of FIX aptamer.  Figure inset is 
cartoon for control experiment. Samples were injected at the flow rate of 10 µl/min. Native-PAGE for 
the specific aptamer-FIX and complementary aptamer-FIX complexes is shown by gel-shift assay.  
Shift and super-shifts were shown with aptamer-FIX.  All experiments were performed with 10 mM 
HEPES buffer (pH 7.4) containing 150 mM NaCl and 2 mM CaCl2.  
 
 
 
Figure 3.15.  Confirmation of FIX and aptamer interaction. (a) Analyses of FIX in plasma with pre-
mixed aptamer.  After immobilization of aptamer  and blocking with N6-PEG on Au surface, plasma 
containing FIX (1:40 dilution) was premixed with different concentrations of specific aptamer (0 to 
375pM) without poly-A tail. Samples were injected at the flow rate of 10 µL/min. All experiments were 
performed with 10 mM HEPES buffer (pH 7.4) containing 150 mM NaCl and 2 mM CaCl2. (b) 
Graphical representation of analyses of aptamer against constant (1:40 dilution) human
plasma mixed with different concentration of aptamer without poly-A tail. 
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Similarly, pre-mix of specific aptamer without poly-A tail (cannot make a duplex with SH-dT20) and FIX, 
causes reduction in the binding with increasing concentration of pre-mixed aptamer (Figure 3.15).  
Results obtained with human plasma using the designed strategy here indicate its suitability to analyse 
the deficiency level of FIX in human blood samples.  
 
3.5. Conclusions 
In this study, using dual PEG-block polymers (PEG-b-PAMA and N6-PEG) co-immobilized Au 
sensing surface of SPR, the detection strategy using was formulated for the detection of FIX with the 
assistance of FIX-aptamer and FIX-antibody as the sandwich pattern.  The detection was performed 
with mouse IgG-GNP.  PEG-b-PAMA treated Au surface promoted the proper orientation of thiolated 
DNA oligos on the Au surface with higher number of molecules. Co-immobilization of N6-PEG with 
PEG-b-PAMA completely abolished the bio-fouling, whereas BSA and ethanolamine have shown 
higher non-specificity. With dual polymers construction the limit of detection was attained to 800 fM, 
further, the selective FIX detection was shown with albumin containing sample.  In addition, the 
concrete of the present polymer assisted detection strategy was proved by detecting FIX in human 
plasma, to be opted for the detection of clinically relevant samples. 
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4.1. Abstract 
Systematic evolution of ligands by exponential enrichment (SELEX) is a selection process for 
identifying high-affinity selective molecules from a randomized combinatorial nucleic acid library 
against a wide range of target molecules.  Using a pool of N25 RNA molecules, the SELEX process 
was performed against two targets from influenza viruses, namely, intact influenza B/Tokio/53/99 and 
hemagglutinin of infuluenza B/Jilin/20/2003. The selection processes were evaluated by surface 
plasmon fluorescence spectroscopy (SPFS), and the result was compared with that obtained by a 
conventional radioisotope method.  Clear discriminations among different selection cycles were 
displayed by SPFS, indicating that this method can be used as an alternative method of radioisotope 
labeling.  The dissociation constant of the selected aptamers against the targets was in the low 
nanomolar range. The sensitivity of the selected aptamer against intact influenza B/Tokio/53/99 to 
detect the influenza virus was low ng/mL level, approximately 250-fold higher sensitivity than that of 
the commercially obtained antibody. The target-binding sites on the aptamer were predicted by 
mapping analyses. The selected aptamer could discriminate other influenza strains and the sensitivity 
of the selected aptamer was further confirmed by gold nanoparticle-based sensing on a waveguide-
mode sensor.  This finding demonstrates that the selected aptamer would be useful for detecting 
influenza viruses at an early stage of infection and for the purpose of influenza surveillance. 
 
4.2. Introduction 
Systematic evolution of ligands by exponential enrichment (SELEX) was developed by 3 
independent researchers in 1990 as an approach to identifying selective molecules among a 
randomized combinatorial library of about 1014 molecules, against organic dyes1 and T4 DNA 
polymerase2  and to alter the cleavage activity of a ribozyme.3  In the past, this SELEX procedure was 
also carried out against targets (aptatopes) of different sizes, ranging from small ligands to the entire 
cell, such as, membrane proteins, human cells and whole viruses.4-7 The SELEX process involves 3 
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vital steps, that is, target binding with the library of molecules, separation of the ligand-aptamer 
complex, and regeneration of bound molecules.  The success of the SELEX process is mainly 
determined by the separation of target-bound molecules from unbound molecules.  After successive 
selection rounds, usually 5–14 cycles, high-affinity molecules are obtained. The high-affinity selective 
molecules obtained after several iterative rounds of SELEX are called “aptamers”.8 Nucleic acid 
libraries involved in the aptamer selection process can be either DNA or RNA.  An RNA library usually 
gives a higher success rate than a DNA library because of the availability of diverse stem-loop 
secondary structures. Due to advantage of diverse possibilies with versatile structures, RNA will yield 
high affinitity aptamers.  Usually, loop regions of the secondary structures of the aptamers contact the 
target molecules through the process of “induced fit”.9  In this study, we chose 2 targets from influenza 
B viruses for aptamer selection. One is intact influenza B/Tokio/53/99 (Tokio-virus) and the other is 
hemagglutinin (HA) of influenza B Jilin/20/2003 (Jilin-HA), which belong to the Yamagata and Victoria 
lineages, respectively.  
 
Influenza is an infectious disease that spreads worldwide with seasonal epidemics, and the 
emergence of different strains because of transmission among them has resulted in deaths.10,11  There 
are three major classes (A, B and C) of influenza viruses and influenza A and B are circulating with 
human population.  Influenza virus has a diameter of about 100 nm, one of the surface proteins of 
influenza, HA play a important role in the infection with host cells through the sialic acids (Figure 4.1).  
Influenza B has the Victoria and Yamagata lineages, and several strains have arisen from these 
types.12 Generating the molecules that can distinguish the closely related viruses with higher 
specificity is a vital issue, especially for global influenza surveillance systems.  With respect to 
pandemic surveillance, the primary goals are to establish detection systems for identifying new 
influenza strains that are different from other existing viruses. Current conventional detection systems 
for influenza viruses mainly rely on immunoassays, which use antibodies as the probe.  
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Immunochromatography test is presently in use for the identification of influenza viruses and for 
discrimination between influenza A and B viruses, using antibody-GNP conjugates.  Generation of 
RNA4 and DNA aptamer13,14 for influenza viruses has been proven to be useful as an alternate 
candidate to antibodies. To generate the system for earlier diagnosis, in the present study, new anti-
influenza aptamers were generated. 
 
 
Figure 4.1. Influenza and host cell interaction.  Two major proteins (HA and NA) are on the surfaces of 
influenza virus. Sialic acid mediates the interactions with HA.   
 
The SELEX process can be monitored or evaluated by various methods that mainly involve 
highly sensitive labeling. The radioisotope labeling method is one of the sensitive methods widely 
used to evaluate the selection processes, however, the facilities available for this method are limited 
and there is some safety issues associated with exposure to radioactive materials.  Among several of 
the labeling techniques, fluorescent labeling is considered to be a sensible detection method.  In our 
study, we used SPFS to assess the processes that are involved in the SELEX and for detection of 
influenza viruses.  SPFS involves a combination of fluorescent labeling and enhancement of 
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fluorescence intensities via electric field enhancement by surface plasmon resonance (SPR), reported 
using fluorescent material on gold,15 latex particles16 and polymers.17  Biomolecular interactions on the 
metal surface with a bound fluorescent label in the vicinity of the enhanced electric field has been 
found to result in appropriate enhancement of output spectral signals.18  In this study, the author 
added cyanine (Cy5) to the 5′ end of polyT (dT20) and enabled complementation with the extended 3′ 
aptamer end with polyA (A24). Cyanine is one of the potential fluorescent compounds effectively used 
in the oligonucleotide-based sensing.19 With this strategy, the author could clearly recognize the 
progression in the SELEX process, and results were supported by the isotope labeling strategy.  
Detection of targets at low concentrations using the developed aptamers was also demonstrated using 
gold nanoparticle-based waveguide-mode sensor.  Further discrimination studies were carried out by 
SPFS using different influenza strains. 
 
4.3. Experimental section 
4.3.1. Reagents and Biomolecules 
3-Aminopropyltriethoxysilane (3-APTES) was purchased from Sigma-Aldrich (Japan).  
Glutaraldehyde and reverse transcriptase (M-MLV, RNase H+) were procured from Wako Chemicals 
(Japan).  Poly(ethylene glycol)-b-poly(acrylic acid) (PEG-b-PAAc) was obtained from General Science 
Corporation, Japan.  Pentaethylenehexamine-terminated PEG (N6-PEG) was provided by JSR 
(Japan).  Dr. GenTLE precipitation carrier, T4 RNA Ligase, and PrimeSTAR Max DNA Polymerase 
were from Takara Bio Inc., Japan.  The Pop-Top Membrane Holder is from Whatman, USA.  H3N2 
virus (A/Panama/2007/1999), Tokio-virus and Jilin-HA were obtained from Prospec-Tany TechnoGene 
Ltd. (Israel). Recombinant hemagglutinin from influenza virus H2N2 (A/Japan/305/1957), H5N1 
(A/chicken/India/NIV33487/2006), and H1N1 (A/California/07/2009), were from Sino Biological Inc. 
China.   Escherichia coli tRNA was obtained from Roche Diagnostics (Germany).  Streptavidin-
conjugated gold nanoparticles (SA-GNPs) [40 nm; 15 optical density (OD)] were from BioAssay Works 
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(USA).  The shorter oligo (dT20) that was conjugated with cyanine (Cy5) or biotin at the 5 end and 
other oligo nucleic acids were synthesized commercially from Tsukuba Oligos, Japan.  Horseradish 
peroxidase-conjugated anti-mouse IgG was obtained from Promega (USA).  Clear Blot membrane-P 
was obtained from ATTO and nitrocellulose membranes were from Millipore (USA).  The ECL-plus 
western blotting detection kit was purchased from Amersham (USA).  Protein markers were obtained 
from Bio-Rad Laboratories Inc. (USA).  All reagents were stored according to the suppliers’ 
recommendations. 
 
4.3.2. Immunoblot analyses   
The specificity of the antibody for the Tokio-virus was analyzed by standard blotting assays as 
described in chapter 3 with an appropriate anti-influenza B antibody.   
 
4.3.3. Preparation of the initial random library  
To generate the RNA library, DNA templates with randomized regions of 25 bases were 
synthesized commercially.  This library was designed with constant 5′ and 3′ primer regions for 
amplifications.  Using the DNA template (5′-GGGAGAATTCCGACCAGAAG–N25–
CCTTTCCTCTCTCCTTCCTCTTCT-3′), the library of DNA molecules was initially amplified by 
polymerase chain reaction (PCR) with 2 PrimeSTAR Max DNA Polymerase (including all dNTPs; 
dATP, dTTP, dGTP and dCTP), forward (5′-
AGTAATACGACTCACTATAGGGAGAATTCCGACCAGAAG-3′) and reverse (5′-
AGAAGAGGAAGGAGAGAGGAAAGG-3′) primers.  The forward primer had the T7 promoter region 
(underlined) at the 5′ end in order to generate RNA molecules during transcription.  The enzymatically 
synthesized double-stranded DNAs were ethanol precipitated, and in vitro transcription reactions were 
performed using T7 RNA polymerase.  Transcription was carried out at 37°C for 3 h with a Cellscript 
transcription kit (Epicentre Biotechnologies, USA).  The products were treated with 2 units of DNase I 
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(RNase free) for 20 min at 37°C to remove the residual template DNA, and the reaction was 
terminated by adding an equal volume of 2 urea buffer (7 M urea, 50 mM ethylenediaminetetraacetic 
acid [EDTA], and 90 mM Tris-borate containing 0.05% bromophenol blue).  Subsequently, the reaction 
mixtures were heated at 94°C for 2 min and loaded on a 12% polyacrylamide gel containing 7 M urea 
to fractionate the product.  The RNA band was visualized under ultraviolet (UV)-shadow and extracted 
from the excised gel piece by the crush and soak method. The RNA was ethanol precipitated, dried 
under vacuum, and redissolved in RNase-free water; the concentration was measured 
spectrophotometrically at 260 nm. 
 
4.3.4. SELEX process 
The SELEX process was carried out using about 1014 RNA molecules with central random 
regions and constant regions at both ends.  The SELEX process is shown in Figure 4.2.  First-round 
selection was done with concentrations of 80 and 38 µg/mL for Tokio-virus and Jilin-HA, respectively.  
Before adding the targets, the RNA library molecules were refolded properly by denaturation at 94ºC 
for 2 min and cooling to room temperature.  The folded RNA molecules were mixed with the targets in 
the presence of HEPES binding buffer (10 mM 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid, 
pH 7.4, 150 mM NaCl, 5 mM MgCl2) and tRNA (10-fold excess of the initial library concentration) 
molecules for competition. Magnesium chloride in the HEPES binding buffer maintains the stability of 
the specific interaction between the target and aptamer.  This mixture was incubated at room 
temperature for 10 min and then passed through the nitrocellulose membrane held on the Pop-Top 
Membrane Holders.  The unbound molecules were discarded by washing with 1 mL of the HEPES 
binding buffer.    The bound molecules that were complexed with the targets and were captured on the 
membrane were recovered by heating at 94ºC with the H2O containing 7 M urea.  The recovered 
solutions with RNA molecules were ethanol precipitated using the Dr. GenTLE precipitation carrier.  
These precipitated molecules were amplified further by a reverse transcription reaction followed by 
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PCR.  Purified molecules were used for the next round of selection, and the processes were repeated 
 
           
Table 4.1: Selection cycles with the target Tokio-virus; ND-Not determined
 
 
           
 Table 4.2: Selection cycles with the target Jilin-HA;  ND - Not determined 
 
with different ratios of targets and competitor (tRNA) (Tables 4.1 & 4.2). In addition to the separation 
strategy using the nitrocellulose membrane, we also used microtiter plate for the separation.  
Separation of the target and aptamer complex by a nitrocellulose membrane was performed with 1st, 
2nd, 5th, 7th, and 9–11th selection cycles for Tokio-virus or 1st, 2nd, 4th, 6th, 7th, and 9–11th 
selection cycles for Jilin-HA.  To remove the molecules that copurified as nonspecific binders during 
the recovery of aptamer from the filters, prefiltration in the absence of target molecules was done 
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between each selection cycle.  Microtiter plate was used with 3rd, 4th, 6th, and 8th selection cycles for 
Tokio-virus or 3rd, 5th, and 8th selection cycles for Jilin-HA.  In this case, the target was covalently 
immobilized on the surface of the microtiter plate and blocked with 3% bovine serum albumin (BSA).   
 
Figure 4.2. Schematic of the systematic evolution of ligands by exponential enrichment (SELEX) 
process.  The steps involved in SELEX include 3 steps: complex formation, separation, and 
amplification.   
 
The non-specific molecules generated from this separation method were removed by pre-negative 
selection on the surface of the microtiter plate coated with only BSA.  The bound molecules from the 
microtiter plate were recovered by adding the 90°C HEPES binding buffer (without MgCl2). 
 
4.3.5. Filter-binding assay  
To check the selection progress by radioisotope labeling, molecules that were obtained from 
SELEX were labeled by incorporating α-ATP (P32) in the transcription reaction described in initial 
random library preparation.  The labeled molecules were fractionated on a 12% polyacrylamide gel 
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containing 7 M urea, and the RNA product was purified as performed in the initial library preparation.  
Using this pure labeled RNA, interactions were carried out using different ratios of the targets in the 
HEPES binding buffer in the presence of tRNA as competitor, and each reaction was incubated at 
room temperature for 10 min and the reaction mixture was filtered on a nitrocellulose membrane fitted 
on a Pop-Top Membrane Holder.  An imaging film was exposed on the membrane for 1 h at room 
temperature.  The exposed film was scanned, and counts were measured on the images of the bound 
molecule.  Based on the count, the bound molecules were calculated using the following formula: 
binding parcentage of molecules (%) = (count of the labeled molecules bound to protein/count of total 
labeled molecules used in the reaction)  100.   
 
4.3.6. Determination of the dissociation constant  
To calculate the dissociation constant (Kd) of the selected aptamer against the targets, we 
labeled the selected aptamer by using PcP (P32) at the 3′ end.  To ligate PcP (P32), an overnight 
reaction was performed at 4°C with the RNA ligase enzyme.  The labeled aptamer was fractionated, 
purified on the 12% polyacrylamide gel containing 7 M urea, and extracted as detailed in the initial 
pool preparation.  Different concentrations of targets (0 to 51.2 µg/mL) were mixed individually with a 
constant concentration (40 nM) of unlabeled aptamer.  Each reaction also included 400 nM of tRNA for 
competition and 5 kcpm of PcP (P32)-labeled aptamer for detection.  These mixtures were incubated in 
the HEPES binding buffer and incubated for 10 min at room temperature, filtered on a nitrocellulose 
membrane, and analyzed.  The values obtained were used to calculate the Kd by using the GraphPad 
Prism software (version 2.1) (http://www.graphpad.com/scientific-software/prism/). 
 
4.3.7. Sensing surface preparation and chemical modification 
To prepare the sensing surface, Cr, Au, and SiO2 were deposited on a S-LAH66 glass substrate 
(Ohara corporation, Japan).  The Cr (0.6 nm) and Au (49 nm) layers are deposited by a vapor-
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depositon method, while the SiO2 (20 nm) is deposited by a rf-magnetron sputtering method. The 
sensing surface was modified by immersion in a 0.5% (v/v) ethanol solution of 3-APTES for 24 h.  The 
3-APTES reacted with the surface hydroxyl groups of SiO2 to give an amine group-functionalized 
substrate that was rinsed with ethanol and dried in a stream of nitrogen gas.  The amine-functionalized 
SiO2 surface was treated with a 2.5% solution of aqueous glutaraldehyde (Glu) for 3 h at room 
temperature to form an aldehyde-activated surface.  The Glu-activated surface allowed for the 
covalent attachment of the targets (Tokio-virus or Jilin-HA). PEG-b-PAAc with a concentration of 4 
mg/mL, was used as the blocking polymer after attaching the targets on the Glu-modified surfaces. 
Previously, the author reported about the specific biomolecular interaction that completely avoided 
charge-based binding on Glu-modified rough surface20 using PEG-b-PAAc on SiO2.
21  
 
 
Figure 4.3. Duplex formation between aptamer and Cy5-labeled ssDNA.  3’ end of aptamer was 
extend with poly-A. A spacer was created for efficient duplex formation. 
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The selected aptamer candidates from the SELEX processes, which were extended with A24 at the 3 
end, were permitted to react on the immobilized target.  The free end of the aptamer with A24 (100 nM) 
was duplexed with Cy5-conjugated dT20 (20 nM) (Figure 4.3).   
 
Figure 4.4. Experimental design to detect influenza virus. (a) Schematic of the chemical surface 
modifications on the SiO2 layer of the sensing plate for aptamer and target interactions.  Glu was 
attached to the amine-modified surface and was followed by target immobilization.  The aptamer 
ending with A24 was attached on the target, and then Cy5 with dT20 was allowed to react.  (b) Setup for 
the surface plasmon resonance spectroscopy (SPFS).  An He-Ne laser was used as the light source.  
The sensing plate with the layers of Cr, Au, and SiO2 was used. 
Chapter 4: Generation of anti-influenza aptamers for sensing applications on PEG-b-PAAc/Fluorescent 
hybridized surface of Surface Plasmon Fluorescence Spectroscopy 
112 
 
 
This complex was measured with emission at 670 nm.  Biomolecular interactions (Figure 4.4a) were 
performed with the incubation of 30 min; after each interaction the sensing surface was thoroughly 
washed 3 times with 450 µL of HEPES binding buffer. 
 
4.3.8. Setup of the SPFS sensor 
The molecules selected from the SELEX process was evaluated by SPFS according to the 
scheme shown in figure 4.4b.  The beam of a He-Ne laser (632.8 nm) was used and it passes through 
a chopper that is connected to a lockin amplifier. The modulated beam then passes through two 
polarizers, by which the intensity and the plane of polarization of the laser can be adjusted. P-
polaraization was selected for the excitation of surface plasmon resonance. A programmable shutter 
was installed to constantly block the laser, thus minimizing the photobleaching effect of the fluorescent 
dyes. The perfluoro “O” ring was mounted between non-fluorescent quartz glass substrate and the 
sensing chip to inject the sample.  The prism was coupled to the substrate of the sensing plate.  The 
“O” ring was connected with an inlet and outlet for liquid exchange.  Approximately 450 L of the 
sample was injected.   The fluorescence emitted from  Cy5 attached on the interactive molecules was 
detected by the photomultiplier, which was placed in front of the sensing plate.   In this experiment, we 
used the cut filter with a wavelength of 680 nm, which is suitable for Cy5.  The light reflected from the 
sensing plate was recognized by a photodiode and recorded by a computer. 
 
4.3.9. Analyses of target-binding sites on the aptamer 
To analyze the binding region of the target protein on the selected aptamer, we performed 
mapping analyses.  Mapping analyses were performed with the ethylnitrosourea (ENU) modifications 
on the backbone of phosphate molecules.  This modification was done with ENU that was saturated 
with ethanol.  To perform this mapping analysis, the selected aptamer was labeled with PcP (P32) and 
purified. The labeled aptamer was reacted with ethanol saturated ENU, in the reaction buffer 
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containing 20 mM HEPES, pH 8.0, and 1 mM EDTA and 2.5 µg of tRNA; it was precipitated using a Dr. 
GenTLE precipitation carrier.  From this ENU-modified aptamer, approximately 100 kcpm was kept 
separate for the negative reaction containing no targets.  Approximately 900 kcpm of the aptamer 
reacted with 40 µg/mL of target (Tokio-virus or Jilin-HA) in the HEPES binding buffer, and unbound 
molecules were removed by membrane filtration followed by washing with 1 mL of the HEPES binding 
buffer.  The aptamers that were bound on the membrane were treated with a mild alkali solution (100 
mM Tris-HCl, pH 9.0) for 10 min at 50ºC.  The ENU-modified aptamer, which was not reacted with the 
target, was simultaneously treated in the same manner.  These mild alkali-treated products were 
ethanol precipitated in the presence of the Dr. GenTLE precipitation carrier and were fractionated on 
12% polyacrylamide gel containing 7 M urea.  To locate the position of the cleaved bases on the gel, 
the labeled aptamers that reacted with alkali solution and were digested with T1 were used as markers.  
For the alkali ladder, labeled products (approximately 20 kcpm) were treated with 50 mM sodium 
carbonate, pH 9.2 at 90ºC for 10 min.  For the T1 enzyme (enzyme that specifically cleaves G bases) 
digestion, a similar amount of labeled aptamer was treated with 0.06 units of enzyme in the 16.5 mM 
sodium citrate, pH 5.0, 0.85 mM EDTA, 7 M urea for 10 min at room temperature.22 To avoid over-
cleavage, both reaction mixtures were also added to 0.3 µg of yeast RNA.  The reactions were 
stopped by adding 2 urea buffer containing bromophenol blue, and the reaction mixtures were loaded 
on a 12% polyacrylamide gel containing 7 M urea. 
 
4.3.10. Setup of the waveguide-mode sensor  
A monolithic sensing plate designed for waveguide-mode sensor comprises a SiO2 glass 
substrate, a single-crystalline Si layer, and a thermally grown SiO2 waveguide.
23  The sensing plate, 
which is illuminated using the Kretschmann configuration, operates as a sensor that is capable of 
detecting modifications in the dielectric environment near the waveguide-mode sensor surface by 
measuring changes in reflectivity.  A halogen lamp was used as a light source.  The light from the lamp 
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was guided to a collimator lens, and a polarizer, and a prism was irradiated with the s-polarized 
collimated light; the incident angle of the light was parallel to the bottom face of the prism.  Then, the 
sensing plate that was placed on the bottom of the prism was illuminated, and a spectrum of the 
reflected light was detected using a spectrophotometer (Ocean Optics, USA).  The prism was made of 
SiO2 glass, and its bottom angle was 38°.  The optical measurements in this study were taken around 
520 nm to show a dip in reflectance, which corresponds to the optical absorption of GNPs.  If GNPs 
are attached to the waveguide-mode sensor surface, the dip will be deepened by the optical 
absorption of the GNPs.24 
 
The surface of the sensing plate was treated similar to the surface modification carried out for 
the SPFS sensing plate. After immobilizing the aptamer, the free extended end of the aptamer with A24 
was duplexed with biotin-dT20. Finally, the biotin–streptavidin interactions were monitored by 
immobilizing SA-GNP in the presence of N6-PEG (0.5 mg/mL). The OD of the SA-GNP solution was 
measured, and the dilutions were prepared using the HEPES binding buffer to obtain a 1 OD SA-GNP 
solution from the original stock supplied.  Each reaction was performed for 30 min on the sensor chip, 
after which the sensing surface was thoroughly washed 3 times with 300 µL of HEPES binding buffer. 
The interaction between Tokio-virus (from 0.8 ng/mL to 8 g/mL) and the aptamer (100 nM) were 
compared with that between Tokio-virus and antibody (100 nM). 
 
4.4. Results and Discussion 
Before being test the interactions of selected molecules from the SELEX process, initially tested 
the non-specific attachment on the Glu-modified surface following blocking with ethanolamine and 
PEG-b-PAAc.  Upon injecting a Cy5-labelled ssDNA (poly-A), the author could observed higher non-
specificity on the ethanolamine-blocked surface, whereas non-specificity was completely quenched on 
PEG-b-PAAc immobilized surface (Figure 4.5).  With this surface having non-fouling was used for 
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further analyses. 
 
Figure 4.5. Determination of blocking efficiency.  Non-specific interaction was evaluated and 
compared between ethanolamine and PEG-b-PAAc. 
 
4.4.1. Evaluation of SELEX processes by SPFS and radioisotope-labeling  
SPFS analyses showed that the binding affinity of the initial randomized library against Tokio-
virus (8 g/mL) was 1.5 times higher than the background level and that the fluorescence count (count 
per second) was 1400 (blue line in the Figure 4.6a), whereas the partially selected molecules from 
different selection cycles (4th, 7th, and 11th cycles) exhibited fluorescence counts of 3700, 27,000, 
and 36,000, respectively (Figure 4.6a & b).  The reflectance spectra obtained during measurements 
are also shown (black line in the figure). The fluorescence intensity show the peaks as positions where 
the reflectance spectra show dips, indicating that the fluorescence is induced by the electric field 
enchanced by SPR. The background fluorescent count with HEPES binding buffer (red line in the 
figure) was approximately 1000, indicating the acceptable levels of signal to noise ratio (S/N). Similarly, 
we also checked the binding affinity of the initial library and the molecules from the 11th cycle with 
Jilin-HA.  It was noticed that the fluorescence count increased from 2400 to 8100 (Figure 4.6c & d). 
The same molecules were also tested by filter-binding assays, aided by radioisotope-labeling with 
Tokio-virus concentration of 2.5 to 10 µg/mL; these assays confirmed the progress in the selection 
 
 
Chapter 4: Generation of anti-influenza aptamers for sensing applications on PEG-b-PAAc/Fluorescent 
hybridized surface of Surface Plasmon Fluorescence Spectroscopy 
116 
 
 
cycles in this study with binding percentages of molecules against Tokio-virus as 0%, 3.7%, 9%, and 
13.5% for the initial library, 4th, 7th, and 11th cycles, respectively.  In the case of Jilin-HA (8 g/mL), 
the selected molecules from the 11th cycle showed binding percentage of 13% and there was no 
binding with the initial library.  The results obtained from both SPFS (Figure 4.6a–d) and filter-binding 
assays (Tables 4.1 & 4.2) clearly showed that the selected molecules include potential aptamer 
candidates for each target. 
 
Figure 4.6. Analyses of interactions between the targets and the molecules selected from different 
stages of selection cycles by SPFS.  (a) Spectral changes with different selection cycles against Tokio-
virus.  The initial, 4th, 7th, and 11th cycles are shown.  The red and blue spectral lines indicate the 
fluorescence levels for HEPES binding buffer and aptamer-target interactions, respectively. (b) 
Graphical representation for the fluorescence intensities in Figure 4.6 (a).  (c) Spectral changes with 
different selection cycles against the target Jilin-HA.  The initial and 11th cycles are shown.  The red 
and blue spectral lines indicate the fluorescence levels for HEPES binding buffer and aptamer-target 
interactions, respectively.   Reflectance spectra (black lines) of the sensing surface covered with buffer, 
obtained by irradiation with laser having wavelength of 632.8 nm. (d) Graphical representation for the 
fluorescence intensities if Figure 4.6(c).  
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Figure 4.7. Secondary structure of the selected clones against (a) Tokio-virus (clones A,B,C and D), 
predicted by the Sfold software (b) Secondary structure of the selected clone against Jilin-HA, 
predicted by the Sfold software.   
 
4.4.2. Aptamer binding analyses  
Because the 11th-cycle molecules had a sufficient binding affinity with their targets, the 
molecules from the 11th cycle were cloned into a TA-vector system, and the individual clones were 
sequenced.  Based on the sequence homologous regions, 4 dominant clones were found for Tokio-
virus and single clone for Jilin-HA (Figure 4.7a & b).  From all the sequenced clones, the frequency of 
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these 4 clones represented 16% of the total population; these molecules contained the common 
sequence motif “GUU”, and these motifs were positioned in the single-stranded regions of the 
secondary structures of the selected clones (Figure 4.8).  These independent clones (A, B, C, and D) 
were tested by the filter-binding assay against the Tokio-virus.  Among these 4 clones, clone D was 
chosen as the best aptamer, it showed the highest binding percentage with 16 µg/mL of Tokio-virus, 
that is, 20% (Figure 4.9a). On the other hand, only 1 predominant clone was found to exist for Jilin-HA 
(Figure 4.7b), and it represented 56% of the total isolated population and exhibited a binding 
percentage of 14% with 16 µg/mL of Jilin-HA (Figure 4.9b). 
 
 
 
Figure 4.8.  Sequences obtained after SELEX process against Tokio-virus.  Four major clones are 
obtaining having a consequence region of ‘GUUU’. Other than these clones having ‘GUU’ region.
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Figure 4.9. Results of the filter binding analyses. (a)  Selected aptamers (clone  A,B, C and D) from 
SELEX process vs Tokio –virus and (b) selected aptamer from SELEX process vs Jilin-HA.  Aptamers 
were labeled by incorporating α-ATP (P32) in the transcription reaction and separated on the gel. After 
making the labeled aptamer and target complex, it was filtered on a nitrocellulose membrane. An 
imaging film was exposed on the membrane and counts were measured. 
 
4.4.3. Determination of the detection limit of the selected aptamers  
To check the detection limit of the selected aptamers, we titrated the target concentration from 
low ng/mL levels to g/mL levels against a constant concentration of the aptamer.   
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Figure 4.10.  Analyses of the selected aptamer against (a) Tokio-virus. Graphical representation for 
the binding analysis with the selected aptamer (clone D) against 0.8 ng/mL to 8 g/mL of Tokio-virus is 
shown.  (b ) Jilin-HA by SPFS. Interactive analyses were performed with the aptamer (100 nM) against 
dose dependent target (8 g/mL to 0.8 ng/mL). Graphical representation for the binding analysis of the 
selected aptamer against 0.8 ng/mL to 8 g/mL of Jilin-HA is shown. The red and blue spectral lines 
indicate the fluorescence levels for the HEPES binding buffer and aptamer-target interactions, 
respectively. The changes in the fluorescence were observed from 8 ng/mL of the targets, and clear 
increase was noticed in a concentration dependent manner. 
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The changes in the fluorescence was observed from 8 ng/mL of Tokio-virus with the selected aptamer 
(clone D), and clear increase was noticed in a concentration dependent manner, and the change were 
saturated at the concentration of 80 ng/mL (Figure 4.10a).  Similarly, the binding between the Jilin-HA 
and aptamer for it was also tested, in this case, the sensitivity level was almost the same as in the 
case of Tokio-virus (about 8 ng/mL) (Figure 4.10b).  Both selected aptamers showed limit of detection 
against the targets at low ng/mL. Detection limit is calculated with the value from 3 times higher 
fluorescence counting than the control experiment.   
 
Figure 4.11. SPFS analyses of complementary sequences of the selected aptamers against Tokio-
virus (a) and Jilin-HA (b). Secondary structures predicted by the Sfold software are shown. The red 
and blue spectral lines indicate the fluorescence levels for the HEPES binding buffer and interactions 
of aptamer-target, respectively. The insets are the results obtained from the filter binding assay.  
Complementary sequences are failed to bind with the targets in both cases. 
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Developing high affinity sensing systems for the detection of influenza viruses has been highly 
encouraged.25,26 Previously, Lee et al.27 proposed an analytical kit to detect influenza viruses and 
showed the sensitivity level of 73 ng/mL. The present analytical detection with the aptamers has one-
order higher sensitivity. The aptamer generated against the Tokio-virus reached saturation at 80 ng/mL 
whereas the aptamer against Jilin-HA reached saturation at 800 ng/mL (Figure 4.10a & b); this 
difference might be attributable to the larger size of the virus compared to that of the HA protein.  
Quantitative work will be required in order to clarify this point. For a control experiment, the author also 
tested the complementary sequences against the targets, and these sequences completely lost their 
binding capacity against the targets (Figure 4.11a & b).  
 
Figure 4.12. Determination of detection limit of the aptamer against Tokio-virus using the waveguide-
mode sensor. Representation for the surface modification is shown.  Interactive analyses were 
performed with the aptamer (100 nM) against dose dependent Tokio-virus. The black and red curves 
are the spectra before and after the attachment of SA-GNP, respectively. Arrows indicate the direction 
of changes in the spectra. Graphical representation of reflectivity changes of selected aptamer vs 
Tokio-virus is shown. 
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Furthermore, these detection limit levels were also confirmed by the waveguide-mode sensor by using 
the aptamers and targets, the measurements were carried out using SA-GNPs.  This GNP hybrid 
sensing system was previously demonstrated to have high sensitivity for the interactions of biotin and 
streptavidin24 and antibody-based detection of influenza viruses.28 Similarly, the aptamer generated in 
this study was evaluated with the respective target in a dose-dependent manner.   
 
 
Figure 4.13. Specificity of the target molecules were determined by (a) Immunochromagraphy test. 
Different amounts of virus was dissolved in the supplied buffer and loaded on the windows of ICT. After 
10 min of incubation the photographs were taken.  Positive band appeared at the virus concentration 4 
µg/mL and above. (b) Dot-blot analyses for primary antibody vs secondary antibody.  Different amount 
of viruses (0.2 to 200 µg/mL) were spotted on the nitrocellulose membrane.  After blocking, the 
specificity of primary antibody interactions with secondary antibody was analyzed using a 1:1000 
dilution of secondary antibody, followed by ECL-plus blotting detection.  (c) Western blot analyses for 
antibody and Tokio-virus. After transfer the protein, the membrane was blocked with 3% nonfat milk 
then treated with a 1:10,000 dilution of the primary antibody. After washing, the membrane was 
incubated with horseradish peroxidase-conjugated goat anti-mouse immunoglobulin G (secondary 
antibody).  The immunocomplexes thus formed were visualized by staining with ECL-plus western 
blotting detection solution. 
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To check the detection limit, we titrated the Tokio-virus concentration from 8 ng/mL  to 16 g/mL 
against constant concentrations of aptamer, PEG-b-PAAc (4 mg/mL), biotin-dT20 (100 nM), and SA-
GNP (1 OD) mixed with 0.5 mg/mL of N6-PEG.  Inclusion of PEG-polymers in the reaction mix for 
biomolecular interactions was reported to increase specificity.21,29  8 ng/mL of Tokio-virus shows the 
reflectivity changes of 4% and the saturation level was 8 g/mL (Figure 4.12).  
Immunochromatography (ICT) was carried out to compare the detection levels of the SPFS and the 
waveguide-mode sensor, and it was clear that both sensors showed higher sensitivity than ICT (Figure 
4.13a). 
 
4.4.4. Comparison of anti-influenza antibody and aptamer  
To compare the aptamer with antibody, the specific interaction of anti-influenza B antibody and 
detection antibody was analyzed by dot-blot analysis, which showed that 200 ng/mL of anti-influenza 
antibody was the ideal dilution (Figure 4.13b).   
Figure 4.14. Binding analyses of antibody against Tokio-virus by waveguide-mode sensor. 
Representation for the surface modification is shown. Interactive analyses were performed with the 
antibody (100 nM) against dose dependent Tokio-virus. The black and red curves are the spectra 
before and after the attachment of SA-GNP, respectively. Arrows indicate the direction of changes in 
the spectra. Graphical representation of reflectivity changes of antibody vs Tokio-virus is shown.   
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The anti-influenza antibody was also evaluated against Tokio-virus by western blot analysis, the 
results clearly showed that the antibody predominantly interacted with HA2 (Figure 4.13c).  Analyses 
with the waveguide-mode sensor by using the antibody against Tokio-virus clearly showed the spectral 
changes until 2 g/mL of Tokio-virus.  Concentrations lower than 2 g/mL did not result in significant 
changes in the spectrum.  The saturation point was 8 g/mL (Figure 4.14).  Similar titration was also 
carried out by SPFS analyses in a dose-dependent manner by using Tokio-virus against the Alexa 
Fluor-conjugated antibody; and the sensitivity was g/mL level (Figure 4.15), which was similar to the 
result obtained in the waveguide-mode sensor. 
 
Figure 4.15. Binding analyses of antibody against Tokio-virus by SPFS. Interactive analyses were 
performed with the antibody (100 nM) against dose dependent Tokio-virus. Clear increment was 
noticed in a concentration dependent manner. The red and blue spectral lines indicate the 
fluorescence levels for the HEPES binding buffer and antibody-Tokio-virus interactions, respectively. 
Graphical representations for the binding analysis of the antibody vs Tokio-virus is shown.  
 
Based on these results with both aptamer and antibody, it was clear that the sensitivity (8 ng/mL) of 
the aptamer is approximately 250-fold higher than that (2 g/mL) of the tested antibody.  The Kd values 
of the abovementioned generated aptamers were evaluated by the filter-binding assay by using the 
targets against the PcP (P32) 3 end-labeled aptamers.  Different concentrations of the targets ranging 
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from 0 to 51.2 µg/mL were used against a constant aptamer concentration.  Based on the statistical 
calculation, the Kd values were determined to be 0.7 ± 0.2 g/mL and 1.2 ± 0.2 g/mL, respectively 
(Figure 4.16a & b), for Tokio-virus and for Jilin-HA. 
 
 
Figure 4.16. Determination of the dissociation constants (Kd) for the selected aptamers.  Targets were 
used in concentrations from 0 to 51.2 µg/mL of target (a) Kd of the selected aptamer against Tokio-
virus.  (b) Kd of the selected aptamer against Jilin-HA.   
 
4.4.5. Potential binding regions of the aptamers  
Using the aptamers generated in this study, we attempted to identify the target-binding regions 
of the aptamer by mapping analyses.  To map the binding region, we performed phosphate 
interference analysis.  Initially, phosphates in the backbone of the aptamers were modified by ethanol-
saturated ENU at 90ºC with 20 mM HEPES, pH 8.0, and 1 mM EDTA.  With this reaction, phosphates 
are modified to a phosphotriester, which would create an ideal situation for mild alkaline cleavage.  It is 
expected to be the modification or incorporation of the ENU in each phosphate moiety. The modified 
aptamers reacted with their target separated from the unbound molecules by membrane filter.  Images 
obtained from the fractionation of these samples by 12% polyacrylamide gel containing 7 M urea 
showed clear profiles and indicated the binding regions for the aptamers by comparing the uncleaved 
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regions in the absence of the target in the gel pattern.  The position of the interferences was predicted 
with alkali- and T1 enzyme-digested aptamer bases.  In the case of the Tokio-virus aptamer, 2 major 
domains were involved in the binding regions. One was in the region from 4 to 26 bases and the other 
was between bases 34 and 38 (Figure 4.17a).   
 
Figure 4.17. Ethylnitrosourea mapping of interfering phosphates of the selected aptamer against (a) 
Tokio-virus  and (b) Jilin-HA. Binding regions are displayed on the secondary structures. 
 
Similarly, in the case of Jilin-HA, the binding regions were found in the following phosphate regions: 
bases 21–27, 33–39, and 44-45 (Figure 4.17b).  In both cases, the region of phosphate inferences 
was on the single-strand loop regions of the secondary structures that were predicted by the Sfold 
online software (http://sfold.wadsworth.org/cgi-bin/index.pl). 
 
4.4.6. Discrimination of influenza viruses  
With the purpose of discriminating the influenza viruses with the selected aptamer in this study, 
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we performed filter-binding analyses with different proteins obtained from different subtypes of the 
influenza viruses belonging to either the A or B type.  Based on the results obtained, the selected 
aptamers against the targets failed to interact with HA of other influenza strains A/California/07/2009 
(H1N1), A/India/NIV33487/2006 (H5N1), and A/Japan/305/1957 (H2N2), or intact virus of 
A/Panama/2007/1999 (H3N2) (Figure 4.18 & Table 4.3).   
 
Figure 4.18.  Analyses of the selected aptamer against different viruses or HA by SPFS.  Spectral 
changes with the anti-Tokio-virus aptamer against, (a) HA from Jilin-HA, (b) HA of A/California/07/2009 
(H1N1), (c) virus A/Pananma/2007/1999 (H3N2). Spectral changes with the anti- Jilin-HA aptamer 
against, (d) Tokio-virus, (e) HA of A/California/07/2009, and (f) virus A/Pananma/2007/1999. The 
concentration of the virus and HA was 8 g/mL. The red and blue spectral lines indicate the 
fluorescence levels for the HEPES binding buffer and aptamer interactions, respectively.  Reflectance 
spectra (black lines) of the sensing surface covered with buffer, obtained by irradiation with laser 
having wavelength of 632.8 nm. 
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These results imply that the selected aptamers are not able to bind with influenza A types.  We also 
investigated the cross-reactivity between the aptamers against Tokio-virus and Jilin-HA.  Similarly, 
discrimination studies were also carried out by SPFS and similar results were obtained (Figure 4.19a–
f).  Based on both studies, aptamer generated against Tokio-virus has predominant binding with whole 
Tokio-virus and there is a possibility that this aptamer may bind to one of the major surface proteins 
[Hemagglutinin (HA) or Neuraminidase (NA)] of Tokio-virus.  More possibility with HA, because it is the 
major protein among all proteins resides in influenza virus. This aptamer lost its binding with Jilin-HA, 
so that the selected aptamer may discriminate Tokio-virus from Jilin-virus. On the other hand, aptamer 
generated against Jilin-HA has a little affinity to Tokio-virus, but it can recognize the Jilin-HA efficiently. 
Taken together, the sensing system shown here, based on fluorescent labeling (SPFS) and GNP-
conjugates (waveguide-mode sensor), will pave the way to develop higher sensititve detection of 
influenza viruses in clinical relevant samples using the generated aptamers. 
 
Table 4.3. Results of discrimination analyses using the selected aptamer against (a) Tokio-virus and 
(b) Jilin-HA obtained by the filter binding assays. 
 
4.5. Conclusions 
Two aptamers were generated with random regions of 25 nucleotides against the Tokio-virus 
(Victoria) and Jilin-HA (Yamagata).  The progression in the selection processes was evaluated by the 
SPFS and conventional radioisotope labeling strategies.  Both aptamers have Kd around 1 µg/mL 
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against their targets.  With the SPFS system and the waveguide-mode sensor, the detection limits 
were determined to be low ng/mL.  Furthermore, the selected aptamers could discriminate HA proteins 
of different influenza viruses.  Sensing system with the generated aptamers shown here can be an 
alternate approach to distinguish the strains belonging to the same type, which would be useful to 
speed up the surveillance of emerging influenza strains.   
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 Developing high-performance nano-biosensors is highly relying on sensitivity and specificity to 
recognize the analyte in the mixture of sample.  To fulfill these criteria, the construction of sensing surface 
with high non-fouling and the choice of probe are mandatory.  The sensing surface construction with 
synthetic polymers is reported to have higher non-fouling, whereas the natural polymers are giving non-
specificity in most of the cases.  Regarding the specific probe, antibody and aptamer are commonly 
considered in sensors developments. However, aptamers are found to have several advantageous over 
antibodies and the consistent developments in the aptamer-based sensors (aptasensors) are widely 
reported.  In the present investigation, using the common sensing substrates (Au and SiO2) the high-
performance aptasensors are demonstrated with the assistance of Poly(ethylene glycol)-(PEG) block 
polymers (PEG-b-polymers); {PEG-b-poly(acrylic acid) (PEG-b-PAAc), pentaethylenehexamine-terminated 
PEG (N6-PEG) and  PEG-b-poly[2-(N,N-dimethylamino)ethyl methacrylate] (PEG-b-PAMA)} using the 
clinically relevant analytes, human blood clotting protein (FIX) and influenza B viruses.  
 
The results obtained are gleaned into 3 chapters (chapters 2, 3 & 4) as summarized below. 
 
Chapter 2: Evanescent-field-coupled Waveguide-mode sensor (PEG-b-PAAc and N6-PEG hybridized SiO2 
surface) 
 
(i) PEG-b-PAAc blocking treatment completely prevents non-specific binding on the SiO2 sensor 
surface and reached the sensitivity to 100 pM for FIX-aptamer interaction. 
(ii) Coating of SA-GNPs by N6-PEG increases the sensitivity by 1000 times (to 100 fM).  
(iii) Higher sensitivity arises from the crowding effect of N6-PEG on the SA-GNPs, which occupy the 
active binding sites on the streptavidin, determined by competition assay and SEM.  
(iv) FIX detection limit of 100 fM was attained even in the presence of other coagulation factors or a 
realistic albumin concentration.  
 
Chapter 3: Surface Plasmon Resonance (PEG-b-PAMA and N6-PEG hybridized Au surface) 
(i) PEG-b-PAMA treated Au surface promoted the proper orientation of thiolated DNA oligos.  
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(ii) Co-immobilization of PEG-b-PAMA and N6-PEG completely abolished the bio-fouling, whereas 
BSA has shown higher non-specificity.  
(iii) The dissociation constant of FIX and aptamer was found as 37 pM in the presence of PEG-b-PAMA 
and N6-PEG. 
(iv) With dual polymer construction the sensitivity was attained to 800 fM with aptamer-FIX-antibody 
sandwich and detected by GNP-conjugated anti-mouse IgG. 
(v) Selective FIX detection was shown with albumin, glubulin containing samples and in human blood 
serum. 
 
Chapter 4: Surface Plasmon Fluorescence Spectroscopy (PEG-b-PAAc hybridized SiO2 surface) 
(i) Two aptamers were generated against influenza viruses (Tokio-virus and Jilin-HA). 
(ii) Both aptamers have the values of Kd in the range of 0.7 to 1.2 µg/mL against their targets. 
(iii) PEG-b-PAAc completely suppresses the non-specific binding of Cy5-conjugated ssDNA on the 
sensing surface.   
(iv) With the SPFS system in the presence of PEG-b-PAAc, the detection limits were determined to be 
low ng/mL, ~ 250-fold higher sensitivity than that of the commercial antibody. 
(iv)  Target-binding sites on the aptamer were predicted by mapping analyses. 
(vi) Selected aptamers could discriminate other influenza viruses.   
 
Through this work, it can be concluded that PEG-b-polymer constructed sensing surface is the 
potential way to develop high-performance faithful sensing systems and herein it is clearly demonstrated 
with different aptasensors.  Further, preference of dual polymers on a given sensing system is shown to be 
with higher sensitive non-biofouling detections. This work will pave way to generate various sensing 
systems with the assistance of PEG-b-polymers for a wide range of ligand and analyte in clinical diagnosis. 
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Appendices 
 
List of Abbreviations and Symbols 
 
A Adenine 
Ag Silver 
AMA 2-(N,N-dimethylamino)ethyl methacrylate  
APS  Ammonium persulfate  
APTES 3-aminopropyltriethoxysilane 
ATP  Adenosine 5’-triphosphate  
Au Gold 
Bis  N, N’-methylene bisacrylamide  
bp Base pair(s)  
BSA  Bovine serum albumin  
C Cytosine 
°C  Degrees Celsius  
CaCl2.6H2O Calcium chloride hexahydrate  
CM5 Carboxymethyl-dextran  
Cr Chromium 
Cy5 Cyanine 5 
dATP Deoxyadenosine triphosphate 
dCTP Deoxycytidine triphosphate 
ddH2O Double-distilled water 
dGTP Deoxyguanosine triphosphate 
DNA  Deoxyribonucleic acid  
DNase  Deoxyribonuclease  
dNTP Deoxyribonucleotide triphosphate  
dsDNA Double-stranded DNA 
DTT Dithiothreitol 
dTTP Deoxythymidine triphosphate 
ECL Enhanced chemiluminescence 
EDC N-ethtyl-N’-(3-dimethylaminopropyl)carbodiimde hydrochloride 
E. coli Escherichia coli  
EDTA  Ethylenediaminetetraacetic Acid  
EFC-WM Evanescent-field-coupled waveguide-mode 
ENU Ethylnitrosourea 
ELISA Enzyme-Linked Immunosorbent Assay 
et al. and others 
EtBr  3, 8-diamino-5-Ethyl-6-phenyl phenanthridinium Bromide  
fM Femtomolar 
FIX Factor IX 
g Gravitational acceleration 
g Gram 
G Guanine 
Gd2O3:Er
3+
,Yb
3+
 gadolinium oxide  
Glu Glutaraldehyde 
GNP Gold nanoparticle 
GTP Guanosine 5’-triphosphate 
h Hour(s)  
HA Hemagglutinin 
HCG Human Chorionic gonadotrophin 
HCl Hydrochloric acid 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
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He-Ne Helium-Neon 
HIV-1 Human immunodeficiency virus-1  
HRP  Horseradish peroxidise  
ICT Immunochromatography test 
IEF Isoelectric focusing 
Ig  Immunoglobulin  
IgE Immunoglobulin E 
IgG Immunoglobulin G 
IgG-GNP Immunoglobulin G conjugated gold nanoparticle 
IPTG  Isopropyl-β-D-thiogalactopyranoside 
Jilin-HA Influenza B/Jilin/20/2003 
KCl Potassium chloride 
kcpm Kilo counts per Minute 
Kd Dissociation constant  
kDa Kilodalton 
Kg Kilogram 
KOH Potassium hydroxide 
KH2PO4 Monopotassium phosphate 
K2HPO4 Dipotassium phosphate 
LB  Luria Bertani medium  
M  Mol/Liter, molar  
MeO-PEG-OH Hydroxyl-terminated poly(ethylene glycol) 
mg Milligram 
MgCl2.6H2O Magnesium Chloride hexahydrate 
Min Minute(s)  
mL Milliliter 
mM Millimolar  
N6-PEG pentaethylenehexamine-terminated poly(ethylene glycol) 
NA Neuraminidase 
Na
+
 Sodium ion 
NaCl Sodium chloride 
ND Not determined 
NaOAc. 3H2O Sodium acetate trihydrate 
NaOH Sodium hydroxide 
ng Nanogram 
NHS N-Hydroxysuccinimide 
nM Nanomolar  
nt Nucleotide(s)  
OD Optical density 
OH Hydroxyl 
PAGE  Polyacrylamide gel electrophoresis  
PBS  Phosphate buffered saline  
PCR  Polymerase chain reaction  
PAAc poly(acrylic acid) 
PEG Poly(ethylene glycol) 
PEG-b-PAAc Poly(ethylene glycol)-b-poly(acrylic acid) 
PEG-b-PAMA Poly(ethylene glycol)-b-poly[2-(N,N-dimethylamino)ethyl 
methacrylate] 
pg Picogram 
pH Potential hydrogen 
pM Picomolar 
pI Isoelectric point 
poly A24 24-mer of poly adenosine 
poly dA poly deoxyadenosine 
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ppm Parts per million 
PVDF Polyvinylidene difluoride 
rf Radio Frequency 
RNA  Ribonucleic acid  
RNase  Ribonuclease  
rpm Rotations per minute  
RT  Room temperature  
RT-PCR Reverse transcription-PCR 
RU Response Unit 
s Second(s)  
SA-GNP Streptavidin-conjugated gold nanoparticle 
SDS  Sodium dodecyl sulfate  
SELEX Systematic Evolution of Ligands by Exponential Enrichment 
SEM Scanning Electron Microscope 
SH-dT Thiolated Deoxythymidine 
Si Silicon 
SiRNA Small interfering Ribonucleic acid 
SiO2 Silicon dioxide 
S/N Signal-to-noise  
SPR Surface Plasmon Resonance 
SPFS Surface Plasmon Fluorescence Spectroscopy 
ssDNA Single-stranded DNA 
T Thymine 
TBE  Tris-Boric Acid-EDTA 
TBS-T Tris Buffered Saline with Tween 20 
TEMED  N,N,N’,N’-Tetramethylethylenediamine  
THF tetrahydrofuran  
Tokio-virus Influenza B/Tokio/53/99 
Tris  Tris-(Hydroxymethyl)-Aminomethane  
tRNA Transfer RNA 
U  Units of enzymatic activity  
UTP Uridine 5’-triphosphate 
UV  Ultraviolet  
Y2O3 Yttrium oxide 
V  Volt (s)  
VEGF  Vesicular Endothelial Growth Factor  
v/v Volume per volume 
w/v  Weight per volume  
X–gal  5’-Bromo-4’-Chloro-3’-Indolyl-β-D-galactoside  
µA Microampere 
µg Microgram 
μL Micro liter  
μM  Micro molar 
2'-F 2'-fluoro 
2'-NH2 2'-amino 
32
P Phosphorus-32 
γ32P Gamma-phosphate 
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Preparation of Buffers & Reagents 
 
Ammonium Persulphate, APS (10%) 
1 g of APS powder was dissolved in 10 mL of ddH2O, aliquoted in several tubes and stored at -20°C. 
 
Ampicilin (100 mg/mL) 
0.5 g of ampicilin was dissolved in ddH2O that amounts up to a final volume of 5 mL. Following filter 
sterilization, the solution was stored in aliquots at -20°C. 
 
Calcium Chloride (1M) 
21.91 g of Calcium chloride hexahydrate (CaCl2.6H2O) powder was dissolved to a final volume of 100 mL 
of ddH2O. The solution was autoclaved at 121°C for 20 min and stored at RT. 
 
Coomassie Briliant blue R250 (0.5%) 
5 g of Coomassie Briliant blue R250, 300 mL of methanol and 100 mL of glacial acetic acid were mixed 
together and made up to a final volume of 1 L with ddH2O. The solution was kept at RT. 
 
Denaturing-urea Polyacrylamide Gel (12%, 7 M) 
420 g of urea, 100 mL of 10X TBE and 400 mL of Acrylamide/Bis–acrylamide (30%) were dissolved in 
ddH2O to a final volume of 1 L. The solution was stored at 4°C. The bottle containing the solution was 
wrapped up with aluminium foil for protection from light. For polymerization, each 10 mL of the solution was 
mixed with 100 µL of 10% APS and 10 µL of TEMED. 
 
Destaining Solution  
300 mL of methanol and 100 mL of glacial acetic acid were mixed together and made up to a final volume 
of 1 L with ddH2O. The solution was kept at RT. 
 
EDTA (Ethylenediaminetetraacetic) (0.5 M, pH 8.0) 
93.06 g of EDTA, Disodium Salt (Dihydrate) was dissolved in 450 mL of ddH2O. The solution was stirred 
while the addition of 10 N NaOH was taking place till the pH of 8.0. Next, the solution was topped up to a 
final volume of 500 mL, autoclaved at 121°C for 20 min and stored at RT. 
 
HEPES-KOH (10X SELEX Binding Buffer) (100 mM HEPES-KOH [pH 7.4], 1500 mM NaCl)  
23.83 g of HEPES and 87.66 g of NaCl were dissolved in 800 mL of ddH2O. The pH was adjusted to 7.4 
with 10 N of KOH. After adjusting the volume to 1 L, the solution was filter-sterilized. The working solution, 
which is 1X, was prepared by mixing 100 mL of the stock solution with 900 mL of autoclaved ddH2O. 
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Isopropyl-β-D-thiogalactopyranoside (IPTG) (100 mM) 
0.238 g of IPTG was dissolved in ddH2O to a total volume of 10 mL, filter-sterilized, aliqouted and stored at 
-20°C. Tubes were covered with aluminium foil for protection from light. 
 
LB Agar containing 100 µg/mL Ampicilin 
10.5 g of LB agar powder was dissolved in ddH2O to a final volume of 300 mL and autoclaved at 121°C for 
20 min. After cooling to about 50°C, 300 µL of 100 mg/mL of ampicilin was added into the solution and 
approximately 20 mL of the solution was poured into each petri plate. After solidification, the petri plates 
were stored at 4°C. For blue-white selection, 50 µL of 40 mg/mL X-Gal and 50 µL of 100 mM IPTG were 
spread on top of the agar and incubated at 37°C for 20 min before used for transformation. 
 
LB Broth/ LB Broth containing 100 µg/mL Ampicilin 
6 g of LB broth powder was dissolved in ddH2O to a final volume of 300 mL and autoclaved at 121°C for 20 
min. The solution was stored at RT. To prepare overnight-grown culture of bacteria, 5 µL of 100 mg/mL of 
ampicilin was added into 5 mL of the LB broth before incubation at 37°C with shaking at 200 rpm for 16 hrs. 
 
Magnesium Chloride (MgCl2) (1 M) 
20.33 g of Magnesium Chloride Hexahydrate (MgCl2.6H2O) powder was dissolved in ddH2O to a final 
volume of 100 mL and autoclaved at 121°C for 20 min. The solution was stored at RT. 
 
Native PAGE (10%) 
50 mL of 10X TBE and 175 mL of Acrylamide/Bis–acrylamide (30%) were dissolved in ddH2O to a final 
volume of 500 mL. The solution was stored at 4°C. For polymerization, each 10 mL of the solution was 
mixed with 100 µL of 10% APS and 10 µL of TEMED. 
 
Phosphate Buffered Saline (PBS) (0.01 M) 
5 PBS tablets were dissolved in ddH2O to a final volume of 1 L and autoclaved at 121°C for 20 min. The 
solution was stored at RT. 
 
PBS containing 3% BSA 
3 g of BSA  was added to a final volume of 100 mL of PBS buffer and stored at 4°C. 
 
PBS containing 0.05% Tween-20 
500 µL of Tween-20 was added into 1 L of PBS buffer and stored at RT. 
 
RNA loading dye (2X) 
4.8 g of urea and 0.5 mL of 1% bromophenol blue were dissolved in 1X TBE to a final volume of 10 mL. 
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The solution was filter-sterilized and stored at RT. 
 
SDS-PAGE Resolving Gel 
2.5 mL of 1.5 M Tris-HCl (pH 8.8), 100 µL of 10% SDS, 4.0 mL Acrylamide/Bis-acrylamide (30%) and 3.3 
mL ddH2O were mixed together. Following this, 100 µL of 10% (w/v) APS and 10 µL of TEMED were added 
for polymerization and poured into the gel casting system. The mixture was overlayed with water. 
 
SDS-PAGE Sample Buffer (5X) 
2 mL of Tris-HCl (0.5 M pH 6.8), 5 mL of 100% glycerol, 1 g of SDS and 0.5 mL of 1% bromophenol blue 
were dissolved in ddH2O to a volume of 10 mL. The mixture was aliquoted 1 mL into each microcentrifuge 
tube and stored at RT. Prior to use, 50 µL of Beta-mercaptoethanol was added into each aliquot. 
 
SDS-PAGE Stacking Gel 
2.0 mL of 0.5 M Tris-HCl (pH 6.8), 80 µL of 10% SDS, 1.3 mL of Acrylamide/Bis-acrylamide (30%), 5.14 mL 
of ddH2O were mixed together. Following this, 80 µL of 10% (w/v) APS and 8 µL of TEMED were added for 
polymerization. The mixture was poured on top of  the solidified resolving gel and comb was inserted. 
 
SDS Running Buffer (10X) 
30.2 g of Tris Base, 144 g of glycine and 10 g of SDS were added into ddH2O, which was adjusted to a final 
volume of 1 L. The solution was stored at RT and was diluted to a working concentration of 1X by mixing 
100 mL of the stock solution with 900 mL of ddH2O. 
 
Sodium Acetate (NaOAc) (3 M, pH 5.2) 
40.8 of Sodium Acetate Trihydrate (NaOAc. 3H2O) was dissolved in 80 mL of ddH2O. After adjusting the pH 
to 5.2 with glacial acetic acid, the solution was topped up to a final volume of 100 mL. The solution was 
autoclaved at 121°C for 20 min and stored at RT. 
 
Sodium Phosphate (50 mM, pH 7.6) 
0.11 g of Monosodium Phosphate, Monohydrate and 1.13 g of Disodium Phosphate, Heptahydrate were 
added to a final volume of 1 L of ddH2O. The solution was autoclaved at 121°C for 20 min and stored at RT. 
 
Tris-Borate-EDTA (TBE) (10X) 
108 g of Tris Base, 55 g of Boric acid and 40 mL of 0.5 M EDTA (pH 8.0) were added to a final volume of 1 
L of ddH2O. Autoclaving of this stock solution was made at 121°C for 20 min. Working solution (1X) was 
prepared by diluting 100 mL of the stock solution with 900 mL of ddH2O. 
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Tris Buffered Saline with Tween 20 (TBS-T) (10X) 
24.23 g of Tris Base, 87.66 of NaCl and 5 mL of Tween-20 were added in ddH2O to a volume of 800 mL. 
After adjusting the pH to 7.5 using 10 N HCl, the solution was topped up to a final volume of 1 L. The 
solution was stored at RT and diluted to a working concentration of 1X by mixing 100 mL of the stock 
solution with 900 mL of ddH2O. The working solution was used as the washing buffer for Western Blot 
analysis. For blocking and antibody preparation, the stock solution was diluted to 1X containing 5 % 
skimmed milk and stored at 4°C. 
 
Tris-HCl (0.5 M, pH 6.8) 
6.1 g of Tris Base powder was dissolved to a final volume of 80 mL of ddH2O and the pH was adjusted to 
6.8 with 10 N of HCl. The volume was brought up to 100 mL. This solution was then autoclaved at 121°C 
for 20 min and stored at RT. 
 
Tris-HCl (1 M, pH 8.3) 
12.2 g of Tris Base powder was dissolved to a final volume of 80 mL of ddH2O and the pH was adjusted to 
8.3 with 10 N of HCl. The volume was added up to 100 mL. This solution was then autoclaved at 121°C for 
20 min and stored at RT. 
 
Tris-HCl (1.5 M, pH 8.8) 
18.3 g of Tris Base powder was dissolved to a final volume of 80 mL of ddH2O and the pH was adjusted to 
8.8 with 10 N of HCl. The volume was added up to 100 mL. This solution was then autoclaved at 121°C for 
20 min and stored at RT. 
 
Tris-HCl (1 M, pH 9.0) 
12.2 g of Tris Base powder was dissolved to a final volume of 80 mL of ddH2O and the pH was adjusted to 
9.0 with 10 N of HCl. The volume was added up to 100 mL of ddH2O. This solution was then autoclaved at 
121°C for 20 min and stored at RT. For mild alkaline hydrolysis in ENU mapping analysis, working 
concentration of 1X was prepared by mixing 100 mL of the stock solution with 900 mL of autoclaved ddH2O.  
 
X-Gal (5-bromo-4-chloro-3-indolyl-β-D- galactopyranoside) (20 mg/mL) 
100 mg of X-Gal powder was dissolved to a final volume of 5 mL of Dimethyl Sulfoxide. After filter-
sterilization, the solution was aliquoted and stored at -20°C. Tubes were wrapped up with aluminium foil for 
protection from light. 
